Hubbry Logo
InfectionInfectionMain
Open search
Infection
Community hub
Infection
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Infection
Infection
from Wikipedia

Infection
Pus oozing from an abscess caused by bacteria
SpecialtyInfectious diseases
CausesBacterial, viral, parasitic, fungal, prion

An infection is the invasion of tissues by pathogens, their multiplication, and the reaction of host tissues to the infectious agent and the toxins they produce.[1] An infectious disease, also known as a transmissible disease or communicable disease, is an illness resulting from an infection.

Infections can be caused by a wide range of pathogens, most prominently bacteria and viruses.[2] Hosts can fight infections using their immune systems. Mammalian hosts react to infections with an innate response, often involving inflammation, followed by an adaptive response.

Treatment for infections depends on the type of pathogen involved. Common medications include:

  • Antibiotics for bacterial infections.
  • Antivirals for viral infections.
  • Antifungals for fungal infections.
  • Antiprotozoals for protozoan infections.
  • Antihelminthics for infections caused by parasitic worms.

Infectious diseases remain a significant global health concern, causing approximately 9.2 million deaths in 2013 (17% of all deaths).[3] The branch of medicine that focuses on infections is referred to as infectious diseases.[4]

Types

[edit]

Infections are caused by infectious agents (pathogens) including:

Signs and symptoms

[edit]

The signs and symptoms of an infection depend on the type of disease. Some signs of infection affect the whole body generally, such as fatigue, loss of appetite, weight loss, fevers, night sweats, chills, aches and pains. Others are specific to individual body parts, such as skin rashes, coughing, or a runny nose.[9]

In certain cases, infectious diseases may be asymptomatic for much or even all of their course in a given host. In the latter case, the disease may only be defined as a "disease" (which by definition means an illness) in hosts who secondarily become ill after contact with an asymptomatic carrier. An infection is not synonymous with an infectious disease, as some infections do not cause illness in a host.[10]

Bacterial or viral

[edit]

As bacterial and viral infections can both cause the same kinds of symptoms, it can be difficult to distinguish which is the cause of a specific infection.[11] Distinguishing the two is important, since viral infections cannot be cured by antibiotics whereas bacterial infections can.[12]

Comparison of viral and bacterial infection
Characteristic Viral infection Bacterial infection
Typical symptoms In general, viral infections are systemic. This means they involve many different parts of the body or more than one body system at the same time; i.e. a runny nose, sinus congestion, cough, body aches etc. They can be local at times as in viral conjunctivitis or "pink eye" and herpes. Only a few viral infections are painful, like herpes. The pain of viral infections is often described as itchy or burning.[11] The classic symptoms of a bacterial infection are localized redness, heat, swelling and pain. One of the hallmarks of a bacterial infection is local pain, pain that is in a specific part of the body. For example, if a cut occurs and is infected with bacteria, pain occurs at the site of the infection. Bacterial throat pain is often characterized by more pain on one side of the throat. An ear infection is more likely to be diagnosed as bacterial if the pain occurs in only one ear.[11] A cut that produces pus and milky-colored liquid is most likely infected.[13]
Cause Pathogenic viruses Pathogenic bacteria

Pathophysiology

[edit]
Chain of infection; the chain of events that lead to infection

There is a general chain of events that applies to infections, sometimes called the chain of infection[14] or transmission chain. The chain of events involves several steps – which include the infectious agent, reservoir, entering a susceptible host, exit and transmission to new hosts. Each of the links must be present in a chronological order for an infection to develop. Understanding these steps helps health care workers target the infection and prevent it from occurring in the first place.[15]

Colonization

[edit]
Infection of an ingrown toenail; there is pus (yellow) and resultant inflammation (redness and swelling around the nail).

Infection begins when an organism successfully enters the body, grows and multiplies. This is referred to as colonization. Most humans are not easily infected. Those with compromised or weakened immune systems have an increased susceptibility to chronic or persistent infections. Individuals who have a suppressed immune system are particularly susceptible to opportunistic infections. Entrance to the host at host–pathogen interface, generally occurs through the mucosa in orifices like the oral cavity, nose, eyes, genitalia, anus, or the microbe can enter through open wounds. While a few organisms can grow at the initial site of entry, many migrate and cause systemic infection in different organs. Some pathogens grow within the host cells (intracellular) whereas others grow freely in bodily fluids.[16]

Wound colonization refers to non-replicating microorganisms within the wound, while in infected wounds, replicating organisms exist and tissue is injured.[17] All multicellular organisms are colonized to some degree by extrinsic organisms, and the vast majority of these exist in either a mutualistic or commensal relationship with the host. An example of the former is the anaerobic bacteria species, which colonizes the mammalian colon, and an example of the latter are the various species of staphylococcus that exist on human skin. Neither of these colonizations are considered infections. The difference between an infection and a colonization is often only a matter of circumstance. Non-pathogenic organisms can become pathogenic given specific conditions, and even the most virulent organism requires certain circumstances to cause a compromising infection. Some colonizing bacteria, such as Corynebacteria sp. and Viridans streptococci, prevent the adhesion and colonization of pathogenic bacteria and thus have a symbiotic relationship with the host, preventing infection and speeding wound healing.

This image depicts the steps of pathogenic infection.[18][19][20]

The variables involved in the outcome of a host becoming inoculated by a pathogen and the ultimate outcome include:

  • the route of entry of the pathogen and the access to host regions that it gains
  • the intrinsic virulence of the particular organism
  • the quantity or load of the initial inoculant
  • the immune status of the host being colonized

As an example, several staphylococcal species remain harmless on the skin, but, when present in a normally sterile space, such as in the capsule of a joint or the peritoneum, multiply without resistance and cause harm.[21]

An interesting fact that gas chromatography–mass spectrometry, 16S ribosomal RNA analysis, omics, and other advanced technologies have made more apparent to humans in recent decades is that microbial colonization is very common even in environments that humans think of as being nearly sterile. Because it is normal to have bacterial colonization, it is difficult to know which chronic wounds can be classified as infected and how much risk of progression exists. Despite the huge number of wounds seen in clinical practice, there are limited quality data for evaluated symptoms and signs. A review of chronic wounds in the Journal of the American Medical Association's "Rational Clinical Examination Series" quantified the importance of increased pain as an indicator of infection.[22] The review showed that the most useful finding is an increase in the level of pain [likelihood ratio (LR) range, 11–20] makes infection much more likely, but the absence of pain (negative likelihood ratio range, 0.64–0.88) does not rule out infection (summary LR 0.64–0.88).

Disease

[edit]

Disease can arise if the host's protective immune mechanisms are compromised and the organism inflicts damage on the host. Microorganisms can cause tissue damage by releasing a variety of toxins or destructive enzymes. For example, Clostridium tetani releases a toxin that paralyzes muscles, and staphylococcus releases toxins that produce shock and sepsis. Not all infectious agents cause disease in all hosts. For example, less than 5% of individuals infected with polio develop disease.[23] On the other hand, some infectious agents are highly virulent. The prion causing mad cow disease and Creutzfeldt–Jakob disease invariably kills all animals and people that are infected.[24]

Persistent infections occur because the body is unable to clear the organism after the initial infection. Persistent infections are characterized by the continual presence of the infectious organism, often as latent infection with occasional recurrent relapses of active infection. There are some viruses that can maintain a persistent infection by infecting different cells of the body. Some viruses once acquired never leave the body. A typical example is the herpes virus, which tends to hide in nerves and become reactivated when specific circumstances arise.[25]

Persistent infections cause millions of deaths globally each year.[26] Chronic infections by parasites account for a high morbidity and mortality in many underdeveloped countries.[27][28]

Transmission

[edit]
A southern house mosquito (Culex quinquefasciatus) is a vector that transmits the pathogens that cause West Nile fever and avian malaria among others.

For infecting organisms to survive and repeat the infection cycle in other hosts, they (or their progeny) must leave an existing reservoir and cause infection elsewhere. Infection transmission can take place via many potential routes:[29]

  • Droplet contact, also known as the respiratory route, and the resultant infection can be termed airborne disease. If an infected person coughs or sneezes on another person the microorganisms, suspended in warm, moist droplets, may enter the body through the nose, mouth or eye surfaces.
  • Fecal-oral transmission, wherein foodstuffs or water become contaminated (by people not washing their hands before preparing food, or untreated sewage being released into a drinking water supply) and the people who eat and drink them become infected. Common fecal-oral transmitted pathogens include Vibrio cholerae, Giardia species, rotaviruses, Entamoeba histolytica, Escherichia coli, and tape worms.[30] Most of these pathogens cause gastroenteritis.
  • Sexual transmission, with the result being called sexually transmitted infection.
  • Oral transmission, diseases that are transmitted primarily by oral means may be caught through direct oral contact such as kissing, or by indirect contact such as by sharing a drinking glass or a cigarette.
  • Transmission by direct contact, Some diseases that are transmissible by direct contact include athlete's foot, impetigo and warts.
  • Vehicle transmission, transmission by an inanimate reservoir (food, water, soil).[31]
  • Vertical transmission, directly from the mother to an embryo, fetus or baby during pregnancy or childbirth. It can occur as a result of a pre-existing infection or one acquired during pregnancy.
  • Iatrogenic transmission, due to medical procedures such as injection or transplantation of infected material.
  • Vector-borne transmission, transmitted by a vector, which is an organism that does not cause disease itself but that transmits infection by conveying pathogens from one host to another.[32]

The relationship between virulence versus transmissibility is complex; with studies have shown that there were no clear relationship between the two.[33][34] There is still a small number of evidence that partially suggests a link between virulence and transmissibility.[35][36][37]

Diagnosis

[edit]

Diagnosis of infectious disease sometimes involves identifying an infectious agent either directly or indirectly.[38] In practice most minor infectious diseases such as warts, cutaneous abscesses, respiratory system infections and diarrheal diseases are diagnosed by their clinical presentation and treated without knowledge of the specific causative agent. Conclusions about the cause of the disease are based upon the likelihood that a patient came in contact with a particular agent, the presence of a microbe in a community, and other epidemiological considerations. Given sufficient effort, all known infectious agents can be specifically identified.[39]

Diagnosis of infectious disease is nearly always initiated by medical history and physical examination. More detailed identification techniques involve the culture of infectious agents isolated from a patient. Culture allows identification of infectious organisms by examining their microscopic features, by detecting the presence of substances produced by pathogens, and by directly identifying an organism by its genotype.[39]

Many infectious organisms are identified without culture and microscopy. This is especially true for viruses, which cannot grow in culture. For some suspected pathogens, doctors may conduct tests that examine a patient's blood or other body fluids for antigens or antibodies that indicate presence of a specific pathogen that the doctor suspects.[39]

Other techniques (such as X-rays, CAT scans, PET scans or NMR) are used to produce images of internal abnormalities resulting from the growth of an infectious agent. The images are useful in detection of, for example, a bone abscess or a spongiform encephalopathy produced by a prion.[40]

The benefits of identification, however, are often greatly outweighed by the cost, as often there is no specific treatment, the cause is obvious, or the outcome of an infection is likely to be benign.[41]

Symptomatic diagnostics

[edit]

The diagnosis is aided by the presenting symptoms in any individual with an infectious disease, yet it usually needs additional diagnostic techniques to confirm the suspicion. Some signs are specifically characteristic and indicative of a disease and are called pathognomonic signs; but these are rare. Not all infections are symptomatic.[42]

In children the presence of cyanosis, rapid breathing, poor peripheral perfusion, or a petechial rash increases the risk of a serious infection by greater than 5 fold.[43] Other important indicators include parental concern, clinical instinct, and temperature greater than 40 °C.[43]

Microbial culture

[edit]
Four nutrient agar plates growing colonies of common Gram negative bacteria

Many diagnostic approaches depend on microbiological culture to isolate a pathogen from the appropriate clinical specimen.[44] In a microbial culture, a growth medium is provided for a specific agent. A sample taken from potentially diseased tissue or fluid is then tested for the presence of an infectious agent able to grow within that medium. Many pathogenic bacteria are easily grown on nutrient agar, a form of solid medium that supplies carbohydrates and proteins necessary for growth, along with copious amounts of water. A single bacterium will grow into a visible mound on the surface of the plate called a colony, which may be separated from other colonies or melded together into a "lawn". The size, color, shape and form of a colony is characteristic of the bacterial species, its specific genetic makeup (its strain), and the environment that supports its growth. Other ingredients are often added to the plate to aid in identification. Plates may contain substances that permit the growth of some bacteria and not others, or that change color in response to certain bacteria and not others. Bacteriological plates such as these are commonly used in the clinical identification of infectious bacterium. Microbial culture may also be used in the identification of viruses: the medium, in this case, being cells grown in culture that the virus can infect, and then alter or kill. In the case of viral identification, a region of dead cells results from viral growth, and is called a "plaque". Eukaryotic parasites may also be grown in culture as a means of identifying a particular agent.[45]

In the absence of suitable plate culture techniques, some microbes require culture within live animals. Bacteria such as Mycobacterium leprae and Treponema pallidum can be grown in animals, although serological and microscopic techniques make the use of live animals unnecessary. Viruses are also usually identified using alternatives to growth in culture or animals. Some viruses may be grown in embryonated eggs. Another useful identification method is Xenodiagnosis, or the use of a vector to support the growth of an infectious agent. Chagas disease is the most significant example, because it is difficult to directly demonstrate the presence of the causative agent, Trypanosoma cruzi in a patient, which therefore makes it difficult to definitively make a diagnosis. In this case, xenodiagnosis involves the use of the vector of the Chagas agent T. cruzi, an uninfected triatomine bug, which takes a blood meal from a person suspected of having been infected. The bug is later inspected for growth of T. cruzi within its gut.[46]

Microscopy

[edit]

Another principal tool in the diagnosis of infectious disease is microscopy.[47] Virtually all of the culture techniques discussed above rely, at some point, on microscopic examination for definitive identification of the infectious agent. Microscopy may be carried out with simple instruments, such as the compound light microscope, or with instruments as complex as an electron microscope. Samples obtained from patients may be viewed directly under the light microscope, and can often rapidly lead to identification. Microscopy is often also used in conjunction with biochemical staining techniques, and can be made exquisitely specific when used in combination with antibody based techniques. For example, the use of antibodies made artificially fluorescent (fluorescently labeled antibodies) can be directed to bind to and identify a specific antigens present on a pathogen. A fluorescence microscope is then used to detect fluorescently labeled antibodies bound to internalized antigens within clinical samples or cultured cells. This technique is especially useful in the diagnosis of viral diseases, where the light microscope is incapable of identifying a virus directly.[48]

Other microscopic procedures may also aid in identifying infectious agents. Almost all cells readily stain with a number of basic dyes due to the electrostatic attraction between negatively charged cellular molecules and the positive charge on the dye. A cell is normally transparent under a microscope, and using a stain increases the contrast of a cell with its background. Staining a cell with a dye such as Giemsa stain or crystal violet allows a microscopist to describe its size, shape, internal and external components and its associations with other cells. The response of bacteria to different staining procedures is used in the taxonomic classification of microbes as well. Two methods, the Gram stain and the acid-fast stain, are the standard approaches used to classify bacteria and to diagnosis of disease. The Gram stain identifies the bacterial groups Bacillota and Actinomycetota, both of which contain many significant human pathogens. The acid-fast staining procedure identifies the Actinomycetota genera Mycobacterium and Nocardia.[49]

Biochemical tests

[edit]

Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.[50]

The isolation of enzymes from infected tissue can also provide the basis of a biochemical diagnosis of an infectious disease. For example, humans can make neither RNA replicases nor reverse transcriptase, and the presence of these enzymes are characteristic., of specific types of viral infections. The ability of the viral protein hemagglutinin to bind red blood cells together into a detectable matrix may also be characterized as a biochemical test for viral infection, although strictly speaking hemagglutinin is not an enzyme and has no metabolic function.[51]

Serological methods are highly sensitive, specific and often extremely rapid tests used to identify microorganisms. These tests are based upon the ability of an antibody to bind specifically to an antigen. The antigen, usually a protein or carbohydrate made by an infectious agent, is bound by the antibody. This binding then sets off a chain of events that can be visibly obvious in various ways, dependent upon the test. For example, "Strep throat" is often diagnosed within minutes, and is based on the appearance of antigens made by the causative agent, S. pyogenes, that is retrieved from a patient's throat with a cotton swab. Serological tests, if available, are usually the preferred route of identification, however the tests are costly to develop and the reagents used in the test often require refrigeration. Some serological methods are extremely costly, although when commonly used, such as with the "strep test", they can be inexpensive.[10]

Complex serological techniques have been developed into what are known as immunoassays. Immunoassays can use the basic antibody – antigen binding as the basis to produce an electro-magnetic or particle radiation signal, which can be detected by some form of instrumentation. Signal of unknowns can be compared to that of standards allowing quantitation of the target antigen. To aid in the diagnosis of infectious diseases, immunoassays can detect or measure antigens from either infectious agents or proteins generated by an infected organism in response to a foreign agent. For example, immunoassay A may detect the presence of a surface protein from a virus particle. Immunoassay B on the other hand may detect or measure antibodies produced by an organism's immune system that are made to neutralize and allow the destruction of the virus.

Instrumentation can be used to read extremely small signals created by secondary reactions linked to the antibody – antigen binding. Instrumentation can control sampling, reagent use, reaction times, signal detection, calculation of results, and data management to yield a cost-effective automated process for diagnosis of infectious disease.

PCR-based diagnostics

[edit]
Nucleic acid testing conducted using an Abbott Laboratories ID Now device

Technologies based upon the polymerase chain reaction (PCR) method will become nearly ubiquitous gold standards of diagnostics of the near future, for several reasons. First, the catalog of infectious agents has grown to the point that virtually all of the significant infectious agents of the human population have been identified. Second, an infectious agent must grow within the human body to cause disease; essentially it must amplify its own nucleic acids to cause a disease. This amplification of nucleic acid in infected tissue offers an opportunity to detect the infectious agent by using PCR. Third, the essential tools for directing PCR, primers, are derived from the genomes of infectious agents, and with time those genomes will be known if they are not already.[52]

Thus, the technological ability to detect any infectious agent rapidly and specifically is currently available. The only remaining blockades to the use of PCR as a standard tool of diagnosis are in its cost and application, neither of which is insurmountable. The diagnosis of a few diseases will not benefit from the development of PCR methods, such as some of the clostridial diseases (tetanus and botulism). These diseases are fundamentally biological poisonings by relatively small numbers of infectious bacteria that produce extremely potent neurotoxins. A significant proliferation of the infectious agent does not occur, this limits the ability of PCR to detect the presence of any bacteria.[52]

Metagenomic sequencing

[edit]

Given the wide range of bacterial, viral, fungal, protozoal, and helminthic pathogens that cause debilitating and life-threatening illnesses, the ability to quickly identify the cause of infection is important yet often challenging. For example, more than half of cases of encephalitis, a severe illness affecting the brain, remain undiagnosed, despite extensive testing using the standard of care (microbiological culture) and state-of-the-art clinical laboratory methods. Metagenomic sequencing-based diagnostic tests are currently being developed for clinical use and show promise as a sensitive, specific, and rapid way to diagnose infection using a single all-encompassing test.[53] This test is similar to current PCR tests; however, an untargeted whole genome amplification is used rather than primers for a specific infectious agent. This amplification step is followed by next-generation sequencing or third-generation sequencing, alignment comparisons, and taxonomic classification using large databases of thousands of pathogen and commensal reference genomes. Simultaneously, antimicrobial resistance genes within pathogen and plasmid genomes are sequenced and aligned to the taxonomically classified pathogen genomes to generate an antimicrobial resistance profile – analogous to antibiotic sensitivity testing – to facilitate antimicrobial stewardship and allow for the optimization of treatment using the most effective drugs for a patient's infection.

Metagenomic sequencing could prove especially useful for diagnosis when the patient is immunocompromised. An ever-wider array of infectious agents can cause serious harm to individuals with immunosuppression, so clinical screening must often be broader. Additionally, the expression of symptoms is often atypical, making a clinical diagnosis based on presentation more difficult. Thirdly, diagnostic methods that rely on the detection of antibodies are more likely to fail. A rapid, sensitive, specific, and untargeted test for all known human pathogens that detects the presence of the organism's DNA rather than antibodies is therefore highly desirable.

Indication of tests

[edit]
A temporary drive-in testing site for COVID-19 set up with tents in a parking lot

There is usually an indication for a specific identification of an infectious agent only when such identification can aid in the treatment or prevention of the disease, or to advance knowledge of the course of an illness prior to the development of effective therapeutic or preventative measures. For example, in the early 1980s, prior to the appearance of AZT for the treatment of AIDS, the course of the disease was closely followed by monitoring the composition of patient blood samples, even though the outcome would not offer the patient any further treatment options. In part, these studies on the appearance of HIV in specific communities permitted the advancement of hypotheses as to the route of transmission of the virus. By understanding how the disease was transmitted, resources could be targeted to the communities at greatest risk in campaigns aimed at reducing the number of new infections. The specific serological diagnostic identification, and later genotypic or molecular identification, of HIV also enabled the development of hypotheses as to the temporal and geographical origins of the virus, as well as a myriad of other hypothesis.[10] The development of molecular diagnostic tools have enabled physicians and researchers to monitor the efficacy of treatment with anti-retroviral drugs. Molecular diagnostics are now commonly used to identify HIV in healthy people long before the onset of illness and have been used to demonstrate the existence of people who are genetically resistant to HIV infection. Thus, while there still is no cure for AIDS, there is great therapeutic and predictive benefit to identifying the virus and monitoring the virus levels within the blood of infected individuals, both for the patient and for the community at large.

Classification

[edit]

Subclinical versus clinical (latent versus apparent)

[edit]

Symptomatic infections are apparent and clinical, whereas an infection that is active but does not produce noticeable symptoms may be called inapparent, silent, subclinical, or occult. An infection that is inactive or dormant is called a latent infection.[54] An example of a latent bacterial infection is latent tuberculosis. Some viral infections can also be latent, examples of latent viral infections are any of those from the Herpesviridae family.[55]

The word infection can denote any presence of a particular pathogen at all (no matter how little) but also is often used in a sense implying a clinically apparent infection (in other words, a case of infectious disease). This fact occasionally creates some ambiguity or prompts some usage discussion; to get around this it is common for health professionals to speak of colonization (rather than infection) when they mean that some of the pathogens are present but that no clinically apparent infection (no disease) is present.[56]

Course of infection

[edit]

Different terms are used to describe how and where infections present over time. In an acute infection, symptoms develop rapidly; its course can either be rapid or protracted. In chronic infection, symptoms usually develop gradually over weeks or months and are slow to resolve.[57] In subacute infections, symptoms take longer to develop than in acute infections but arise more quickly than those of chronic infections. A focal infection is an initial site of infection from which organisms travel via the bloodstream to another area of the body.[58]

Primary versus opportunistic

[edit]

Among the many varieties of microorganisms, relatively few cause disease in otherwise healthy individuals.[59] Infectious disease results from the interplay between those few pathogens and the defenses of the hosts they infect. The appearance and severity of disease resulting from any pathogen depend upon the ability of that pathogen to damage the host as well as the ability of the host to resist the pathogen. However, a host's immune system can also cause damage to the host itself in an attempt to control the infection. Clinicians, therefore, classify infectious microorganisms or microbes according to the status of host defenses – either as primary pathogens or as opportunistic pathogens.[60]

Primary pathogens
[edit]

Primary pathogens cause disease as a result of their presence or activity within the normal, healthy host, and their intrinsic virulence (the severity of the disease they cause) is, in part, a necessary consequence of their need to reproduce and spread. Many of the most common primary pathogens of humans only infect humans, however, many serious diseases are caused by organisms acquired from the environment or that infect non-human hosts.[61]

Opportunistic pathogens
[edit]

Opportunistic pathogens can cause an infectious disease in a host with depressed resistance (immunodeficiency) or if they have unusual access to the inside of the body (for example, via trauma). Opportunistic infection may be caused by microbes ordinarily in contact with the host, such as pathogenic bacteria or fungi in the gastrointestinal or the upper respiratory tract, and they may also result from (otherwise innocuous) microbes acquired from other hosts (as in Clostridioides difficile colitis) or from the environment as a result of traumatic introduction (as in surgical wound infections or compound fractures). An opportunistic disease requires impairment of host defenses, which may occur as a result of genetic defects (such as chronic granulomatous disease), exposure to antimicrobial drugs or immunosuppressive chemicals (as might occur following poisoning or cancer chemotherapy), exposure to ionizing radiation, or as a result of an infectious disease with immunosuppressive activity (such as with measles, malaria or HIV disease). Primary pathogens may also cause more severe disease in a host with depressed resistance than would normally occur in an immunosufficient host.[10]

Secondary infection
[edit]

While a primary infection can practically be viewed as the root cause of an individual's current health problem, a secondary infection is a sequela or complication of that root cause. For example, an infection due to a burn or penetrating trauma (the root cause) is a secondary infection. Primary pathogens often cause primary infection and often cause secondary infection. Usually, opportunistic infections are viewed as secondary infections (because immunodeficiency or injury was the predisposing factor).[60]

Other types of infection
[edit]

Other types of infection consist of mixed, iatrogenic, nosocomial, and community-acquired infection. A mixed infection is an infection that is caused by two or more pathogens. An example of this is appendicitis, which is caused by Bacteroides fragilis and Escherichia coli. The second is an iatrogenic infection. This type of infection is one that is transmitted from a health care worker to a patient. A nosocomial infection is also one that occurs in a health care setting. Nosocomial infections are those that are acquired during a hospital stay. Lastly, a community-acquired infection is one in which the infection is acquired from a whole community.[58]

Infectious or not

[edit]

One manner of proving that a given disease is infectious, is to satisfy Koch's postulates (first proposed by Robert Koch), which require that first, the infectious agent be identifiable only in patients who have the disease, and not in healthy controls, and second, that patients who contract the infectious agent also develop the disease. These postulates were first used in the discovery that Mycobacteria species cause tuberculosis.[62]

However, Koch's postulates cannot usually be tested in modern practice for ethical reasons. Proving them would require experimental infection of a healthy individual with a pathogen produced as a pure culture. Conversely, even clearly infectious diseases do not always meet the infectious criteria; for example, Treponema pallidum, the causative spirochete of syphilis, cannot be cultured in vitro – however the organism can be cultured in rabbit testes. It is less clear that a pure culture comes from an animal source serving as host than it is when derived from microbes derived from plate culture.[63]

Epidemiology, or the study and analysis of who, why and where disease occurs, and what determines whether various populations have a disease, is another important tool used to understand infectious disease. Epidemiologists may determine differences among groups within a population, such as whether certain age groups have a greater or lesser rate of infection; whether groups living in different neighborhoods are more likely to be infected; and by other factors, such as gender and race. Researchers also may assess whether a disease outbreak is sporadic, or just an occasional occurrence; endemic, with a steady level of regular cases occurring in a region; epidemic, with a fast arising, and unusually high number of cases in a region; or pandemic, which is a global epidemic. If the cause of the infectious disease is unknown, epidemiology can be used to assist with tracking down the sources of infection.[64]

Contagiousness

[edit]

Infectious diseases are sometimes called contagious diseases when they are easily transmitted by contact with an ill person or their secretions (e.g., influenza). Thus, a contagious disease is a subset of infectious disease that is especially infective or easily transmitted. All contagious diseases are infectious, but not vice versa.[65][66] Other types of infectious, transmissible, or communicable diseases with more specialized routes of infection, such as vector transmission or sexual transmission, are usually not regarded as "contagious", and often do not require medical isolation (sometimes loosely called quarantine) of those affected. However, this specialized connotation of the word "contagious" and "contagious disease" (easy transmissibility) is not always respected in popular use.

Infectious diseases are commonly transmitted from person to person through direct contact. The types of direct contact are through person to person and droplet spread. Indirect contact such as airborne transmission, contaminated objects, food and drinking water, animal person contact, animal reservoirs, insect bites, and environmental reservoirs are another way infectious diseases are transmitted. The basic reproduction number of an infectious disease measures how easily it spreads through direct or indirect contact.[67][68]

By anatomic location

[edit]

Infections can be classified by the anatomic location or organ system infected, including:[69][citation needed]

In addition, locations of inflammation where infection is the most common cause include pneumonia, meningitis and salpingitis.[70]

Prevention

[edit]
Washing one's hands, a form of hygiene, is an effective way to prevent the spread of infectious disease.[71]

Techniques like hand washing, wearing gowns, and wearing face masks can help prevent infections from being passed from one person to another. Aseptic technique was introduced in medicine and surgery in the late 19th century and greatly reduced the incidence of infections caused by surgery. Frequent hand washing remains the most important defense against the spread of unwanted organisms.[72] There are other forms of prevention such as avoiding the use of illicit drugs, using a condom, wearing gloves, and having a healthy lifestyle with a balanced diet and regular exercise. Cooking foods well and avoiding foods that have been left outside for a long time is also important.[citation needed]

Antimicrobial substances used to prevent transmission of infections include:[citation needed]

  • antiseptics, which are applied to living tissue/skin
  • disinfectants, which destroy microorganisms found on non-living objects.
  • antibiotics, called prophylactic when given as prevention rather as treatment of infection. However, long term use of antibiotics leads to resistance of bacteria. While humans do not become immune to antibiotics, the bacteria does. Thus, avoiding using antibiotics longer than necessary helps preventing bacteria from forming mutations that aide in antibiotic resistance.

One of the ways to prevent or slow down the transmission of infectious diseases is to recognize the different characteristics of various diseases.[73] Some critical disease characteristics that should be evaluated include virulence, distance traveled by those affected, and level of contagiousness. The human strains of Ebola virus, for example, incapacitate those infected extremely quickly and kill them soon after. As a result, those affected by this disease do not have the opportunity to travel very far from the initial infection zone.[74] Also, this virus must spread through skin lesions or permeable membranes such as the eye. Thus, the initial stage of Ebola is not very contagious since its victims experience only internal hemorrhaging. As a result of the above features, the spread of Ebola is very rapid and usually stays within a relatively confined geographical area. In contrast, the human immunodeficiency virus (HIV) kills its victims very slowly by attacking their immune system.[10] As a result, many of its victims transmit the virus to other individuals before even realizing that they are carrying the disease. Also, the relatively low virulence allows its victims to travel long distances, increasing the likelihood of an epidemic.[citation needed]

Another effective way to decrease the transmission rate of infectious diseases is to recognize the effects of small-world networks.[73] In epidemics, there are often extensive interactions within hubs or groups of infected individuals and other interactions within discrete hubs of susceptible individuals. Despite the low interaction between discrete hubs, the disease can jump and spread in a susceptible hub via a single or few interactions with an infected hub. Thus, infection rates in small-world networks can be reduced somewhat if interactions between individuals within infected hubs are eliminated (Figure 1). However, infection rates can be drastically reduced if the main focus is on the prevention of transmission jumps between hubs. The use of needle exchange programs in areas with a high density of drug users with HIV is an example of the successful implementation of this treatment method.[75] Another example is the use of ring culling or vaccination of potentially susceptible livestock in adjacent farms to prevent the spread of the foot-and-mouth virus in 2001.[76]

A general method to prevent transmission of vector-borne pathogens is pest control.

In cases where infection is merely suspected, individuals may be quarantined until the incubation period has passed and the disease manifests itself or the person remains healthy. Groups may undergo quarantine, or in the case of communities, a cordon sanitaire may be imposed to prevent infection from spreading beyond the community, or in the case of protective sequestration, into a community. Public health authorities may implement other forms of social distancing, such as school closings, lockdowns or temporary restrictions (e.g. circuit breakers)[77] to control an epidemic.

Immunity

[edit]
Mary Mallon (a.k.a. Typhoid Mary) was an asymptomatic carrier of typhoid fever. Over the course of her career as a cook, she infected 53 people, three of whom died.

Infection with most pathogens does not result in death of the host and the offending organism is ultimately cleared after the symptoms of the disease have waned.[59] This process requires immune mechanisms to kill or inactivate the inoculum of the pathogen. Specific acquired immunity against infectious diseases may be mediated by antibodies and/or T lymphocytes. Immunity mediated by these two factors may be manifested by:

  • a direct effect upon a pathogen, such as antibody-initiated complement-dependent bacteriolysis, opsonoization, phagocytosis and killing, as occurs for some bacteria,
  • neutralization of viruses so that these organisms cannot enter cells,
  • or by T lymphocytes, which will kill a cell parasitized by a microorganism.

The immune system response to a microorganism often causes symptoms such as a high fever and inflammation, and has the potential to be more devastating than direct damage caused by a microbe.[10]

Resistance to infection (immunity) may be acquired following a disease, by asymptomatic carriage of the pathogen, by harboring an organism with a similar structure (crossreacting), or by vaccination. Knowledge of the protective antigens and specific acquired host immune factors is more complete for primary pathogens than for opportunistic pathogens. There is also the phenomenon of herd immunity which offers a measure of protection to those otherwise vulnerable people when a large enough proportion of the population has acquired immunity from certain infections.[78]

Immune resistance to an infectious disease requires a critical level of either antigen-specific antibodies and/or T cells when the host encounters the pathogen. Some individuals develop natural serum antibodies to the surface polysaccharides of some agents although they have had little or no contact with the agent, these natural antibodies confer specific protection to adults and are passively transmitted to newborns.

Host genetic factors

[edit]

The organism that is the target of an infecting action of a specific infectious agent is called the host. The host harbouring an agent that is in a mature or sexually active stage phase is called the definitive host. The intermediate host comes in contact during the larvae stage. A host can be anything living and can attain to asexual and sexual reproduction.[79] The clearance of the pathogens, either treatment-induced or spontaneous, it can be influenced by the genetic variants carried by the individual patients. For instance, for genotype 1 hepatitis C treated with Pegylated interferon-alpha-2a or Pegylated interferon-alpha-2b (brand names Pegasys or PEG-Intron) combined with ribavirin, it has been shown that genetic polymorphisms near the human IL28B gene, encoding interferon lambda 3, are associated with significant differences in the treatment-induced clearance of the virus. This finding, originally reported in Nature,[80] showed that genotype 1 hepatitis C patients carrying certain genetic variant alleles near the IL28B gene are more possibly to achieve sustained virological response after the treatment than others. Later report from Nature[81] demonstrated that the same genetic variants are also associated with the natural clearance of the genotype 1 hepatitis C virus.

Treatments

[edit]

When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antiprotozoal and antihelminthic) agents. Depending on the severity and the type of infection, the antibiotic may be given by mouth or by injection, or may be applied topically. Severe infections of the brain are usually treated with intravenous antibiotics. Sometimes, multiple antibiotics are used in case there is resistance to one antibiotic. Antibiotics only work for bacteria and do not affect viruses. Antibiotics work by slowing down the multiplication of bacteria or killing the bacteria. The most common classes of antibiotics used in medicine include penicillin, cephalosporins, aminoglycosides, macrolides, quinolones and tetracyclines.[82][83]

Not all infections require treatment, and for many self-limiting infections the treatment may cause more side-effects than benefits. Antimicrobial stewardship is the concept that healthcare providers should treat an infection with an antimicrobial that specifically works well for the target pathogen for the shortest amount of time and to only treat when there is a known or highly suspected pathogen that will respond to the medication.[84]

Susceptibility to infection

[edit]

Pandemics such as COVID-19 show that people dramatically differ in their susceptibility to infection. This may be because of general health, age, or their immune status, e.g. when they have been infected previously. However, it also has become clear that there are genetic factor which determine susceptibility to infection. For instance, up to 40% of SARS-CoV-2 infections may be asymptomatic, suggesting that many people are naturally protected from disease.[85] Large genetic studies have defined risk factors for severe SARS-CoV-2 infections, and genome sequences from 659 patients with severe COVID-19 revealed genetic variants that appear to be associated with life-threatening disease. One gene identified in these studies is type I interferon (IFN). Autoantibodies against type I IFNs were found in up to 13.7% of patients with life-threatening COVID-19, indicating that a complex interaction between genetics and the immune system is important for natural resistance to Covid.[86]

Similarly, mutations in the ERAP2 gene, encoding endoplasmic reticulum aminopeptidase 2, seem to increase the susceptibility to the plague, the disease caused by an infection with the bacteria Yersinia pestis. People who inherited two copies of a complete variant of the gene were twice as likely to have survived the plague as those who inherited two copies of a truncated variant.[87]

Susceptibility also determined the epidemiology of infection, given that different populations have different genetic and environmental conditions that affect infections.

Epidemiology

[edit]
Death rates from infectious disease
Disability-adjusted life year for infectious and parasitic diseases per 100,000 inhabitants in 2004:[88]
  •   no data
  •   ≤250
  •   250–500
  •   500–1000
  •   1000–2000
  •   2000–3000
  •   3000–4000
  •   4000–5000
  •   5000–6250
  •   6250–12,500
  •   12,500–25,000
  •   25,000–50,000
  •   ≥50,000

An estimated 1,680 million people died of infectious diseases in the 20th century[89] and about 10 million in 2010.[90]

The World Health Organization collects information on global deaths by International Classification of Disease (ICD) code categories. The following table lists the top infectious disease by number of deaths in 2002. 1993 data is included for comparison.

Worldwide mortality due to infectious diseases[91][92]
Rank Cause of death Deaths 2002
(in millions)
Percentage of
all deaths
Deaths 1993
(in millions)
1993 Rank
N/A All infectious diseases 14.7 25.9% 16.4 32.2%
1 Lower respiratory infections[93] 3.9 6.9% 4.1 1
2 HIV/AIDS 2.8 4.9% 0.7 7
3 Diarrheal diseases[94] 1.8 3.2% 3.0 2
4 Tuberculosis (TB) 1.6 2.7% 2.7 3
5 Malaria 1.3 2.2% 2.0 4
6 Measles 0.6 1.1% 1.1 5
7 Pertussis 0.29 0.5% 0.36 7
8 Tetanus 0.21 0.4% 0.15 12
9 Meningitis 0.17 0.3% 0.25 8
10 Syphilis 0.16 0.3% 0.19 11
11 Hepatitis B 0.10 0.2% 0.93 6
12–17 Tropical diseases (6)[95] 0.13 0.2% 0.53 9, 10, 16–18
Note: Other causes of death include maternal and perinatal conditions (5.2%), nutritional deficiencies (0.9%),
noncommunicable conditions (58.8%), and injuries (9.1%).

The top three single agent/disease killers are HIV/AIDS, TB and malaria. While the number of deaths due to nearly every disease have decreased, deaths due to HIV/AIDS have increased fourfold. Childhood diseases include pertussis, poliomyelitis, diphtheria, measles and tetanus. Children also make up a large percentage of lower respiratory and diarrheal deaths. In 2012, approximately 3.1 million people have died due to lower respiratory infections, making it the number 4 leading cause of death in the world.[96]

Historic pandemics

[edit]
The Great Plague of Marseille in 1720 killed 100,000 people in the city and the surrounding provinces.

With their potential for unpredictable and explosive impacts, infectious diseases have been major actors in human history.[97] A pandemic (or global epidemic) is a disease that affects people over an extensive geographical area. For example:

  • Plague of Justinian, from 541 to 542, killed between 50% and 60% of Europe's population.[98]
  • The Black Death of 1347 to 1352 killed 25 million in Europe over five years. The plague reduced the old world population from an estimated 450 million to between 350 and 375 million in the 14th century.
  • The introduction of smallpox, measles, and typhus to the areas of Central and South America by European explorers during the 15th and 16th centuries caused pandemics among the native inhabitants. Between 1518 and 1568 disease pandemics are said to have caused the population of Mexico to fall from 20 million to 3 million.[99]
  • The first European influenza epidemic occurred between 1556 and 1560, with an estimated mortality rate of 20%.[99]
  • Smallpox killed an estimated 60 million Europeans during the 18th century[100] (approximately 400,000 per year).[101] Up to 30% of those infected, including 80% of the children under 5 years of age, died from the disease, and one-third of the survivors went blind.[102]
  • In the 19th century, tuberculosis killed an estimated one-quarter of the adult population of Europe;[103] by 1918 one in six deaths in France were still caused by TB.
  • The Influenza Pandemic of 1918 (or the Spanish flu) killed 25–50 million people (about 2% of world population of 1.7 billion).[104] Today Influenza kills about 250,000 to 500,000 worldwide each year.
  • In 2021, COVID-19 emerged as a major global health crisis, directly causing 8.7 million deaths, making it one of the leading causes of mortality worldwide.[105]

Emerging diseases

[edit]

In most cases, microorganisms live in harmony with their hosts via mutual or commensal interactions. Diseases can emerge when existing parasites become pathogenic or when new pathogenic parasites enter a new host.

  1. Coevolution between parasite and host can lead to hosts becoming resistant to the parasites or the parasites may evolve greater virulence, leading to immunopathological disease.
  2. Human activity is involved with many emerging infectious diseases, such as environmental change enabling a parasite to occupy new niches. When that happens, a pathogen that had been confined to a remote habitat has a wider distribution and possibly a new host organism. Parasites jumping from nonhuman to human hosts are known as zoonoses. Under disease invasion, when a parasite invades a new host species, it may become pathogenic in the new host.[106]

Several human activities have led to the emergence of zoonotic human pathogens, including viruses, bacteria, protozoa, and rickettsia,[107] and spread of vector-borne diseases,[106] see also globalization and disease and wildlife disease:

  • Encroachment on wildlife habitats. The construction of new villages and housing developments in rural areas force animals to live in dense populations, creating opportunities for microbes to mutate and emerge.[108]
  • Changes in agriculture. The introduction of new crops attracts new crop pests and the microbes they carry to farming communities, exposing people to unfamiliar diseases.
  • The destruction of rain forests. As countries make use of their rain forests, by building roads through forests and clearing areas for settlement or commercial ventures, people encounter insects and other animals harboring previously unknown microorganisms.
  • Uncontrolled urbanization. The rapid growth of cities in many developing countries tends to concentrate large numbers of people into crowded areas with poor sanitation. These conditions foster transmission of contagious diseases.
  • Modern transport. Ships and other cargo carriers often harbor unintended "passengers", that can spread diseases to faraway destinations. While with international jet-airplane travel, people infected with a disease can carry it to distant lands, or home to their families, before their first symptoms appear.

Germ theory of disease

[edit]

In Antiquity, the Greek historian Thucydides (c. 460c. 400 BCE) was the first person to write, in his account of the plague of Athens, that diseases could spread from an infected person to others.[109][110] In his On the Different Types of Fever (c. 175 AD), the Greco-Roman physician Galen speculated that plagues were spread by "certain seeds of plague", which were present in the air.[111] In the Sushruta Samhita, the ancient Indian physician Sushruta theorized: "Leprosy, fever, consumption, diseases of the eye, and other infectious diseases spread from one person to another by sexual union, physical contact, eating together, sleeping together, sitting together, and the use of same clothes, garlands and pastes."[112][113] This book has been dated to about the sixth century BC.[114]

A basic form of contagion theory was proposed by Persian physician Ibn Sina (known as Avicenna in Europe) in The Canon of Medicine (1025), which later became the most authoritative medical textbook in Europe up until the 16th century. In Book IV of the Canon, Ibn Sina discussed epidemics, outlining the classical miasma theory and attempting to blend it with his own early contagion theory. He mentioned that people can transmit disease to others by breath, noted contagion with tuberculosis, and discussed the transmission of disease through water and dirt.[115] The concept of invisible contagion was later discussed by several Islamic scholars in the Ayyubid Sultanate who referred to them as najasat ("impure substances"). The fiqh scholar Ibn al-Haj al-Abdari (c. 1250–1336), while discussing Islamic diet and hygiene, gave warnings about how contagion can contaminate water, food, and garments, and could spread through the water supply, and may have implied contagion to be unseen particles.[116]

When the Black Death bubonic plague reached Al-Andalus in the 14th century, the Arab physicians Ibn Khatima (c. 1369) and Ibn al-Khatib (1313–1374) hypothesised that infectious diseases were caused by "minute bodies" and described how they can be transmitted through garments, vessels and earrings.[117] Ideas of contagion became more popular in Europe during the Renaissance, particularly through the writing of the Italian physician Girolamo Fracastoro.[118] Anton van Leeuwenhoek (1632–1723) advanced the science of microscopy by being the first to observe microorganisms, allowing for easy visualization of bacteria.

In the mid-19th century John Snow and William Budd did important work demonstrating the contagiousness of typhoid and cholera through contaminated water. Both are credited with decreasing epidemics of cholera in their towns by implementing measures to prevent contamination of water.[119] Louis Pasteur proved beyond doubt that certain diseases are caused by infectious agents, and developed a vaccine for rabies. Robert Koch provided the study of infectious diseases with a scientific basis known as Koch's postulates. Edward Jenner, Jonas Salk and Albert Sabin developed effective vaccines for smallpox and polio, which would later result in the eradication and near-eradication of these diseases, respectively. Alexander Fleming discovered the world's first antibiotic, penicillin, which Florey and Chain then developed. Gerhard Domagk developed sulphonamides, the first broad spectrum synthetic antibacterial drugs.[citation needed]

Medical specialists

[edit]

The medical treatment of infectious diseases falls into the medical field of Infectious Disease and in some cases the study of propagation pertains to the field of Epidemiology. Generally, infections are initially diagnosed by primary care physicians or internal medicine specialists. For example, an "uncomplicated" pneumonia will generally be treated by the internist or the pulmonologist (lung physician). The work of the infectious diseases specialist therefore entails working with both patients and general practitioners, as well as laboratory scientists, immunologists, bacteriologists and other specialists.[120]

An infectious disease team may be alerted when:[citation needed]

Society and culture

[edit]

Several studies have reported associations between pathogen load in an area and human behavior. Higher pathogen load is associated with decreased size of ethnic and religious groups in an area. This may be due high pathogen load favoring avoidance of other groups, which may reduce pathogen transmission, or a high pathogen load preventing the creation of large settlements and armies that enforce a common culture. Higher pathogen load is also associated with more restricted sexual behavior, which may reduce pathogen transmission. It also associated with higher preferences for health and attractiveness in mates. Higher fertility rates and shorter or less parental care per child is another association that may be a compensation for the higher mortality rate. There is also an association with polygyny which may be due to higher pathogen load, making selecting males with a high genetic resistance increasingly important. Higher pathogen load is also associated with more collectivism and less individualism, which may limit contacts with outside groups and infections. There are alternative explanations for at least some of the associations although some of these explanations may in turn ultimately be due to pathogen load. Thus, polygyny may also be due to a lower male: female ratio in these areas but this may ultimately be due to male infants having increased mortality from infectious diseases. Another example is that poor socioeconomic factors may ultimately in part be due to high pathogen load preventing economic development.[121]

Fossil record

[edit]
Skull of dinosaur with long jaws and teeth.
Herrerasaurus skull

Evidence of infection in fossil remains is a subject of interest for paleopathologists, scientists who study occurrences of injuries and illness in extinct life forms. Signs of infection have been discovered in the bones of carnivorous dinosaurs. When present, however, these infections seem to tend to be confined to only small regions of the body. A skull attributed to the early carnivorous dinosaur Herrerasaurus ischigualastensis exhibits pit-like wounds surrounded by swollen and porous bone. The unusual texture of the bone around the wounds suggests they were affected by a short-lived, non-lethal infection. Scientists who studied the skull speculated that the bite marks were received in a fight with another Herrerasaurus. Other carnivorous dinosaurs with documented evidence of infection include Acrocanthosaurus, Allosaurus, Tyrannosaurus and a tyrannosaur from the Kirtland Formation. The infections from both tyrannosaurs were received by being bitten during a fight, like the Herrerasaurus specimen.[122]

Outer space

[edit]

A 2006 Space Shuttle experiment found that Salmonella typhimurium, a bacterium that can cause food poisoning, became more virulent when cultivated in space.[123] On April 29, 2013, scientists in Rensselaer Polytechnic Institute, funded by NASA, reported that, during spaceflight on the International Space Station, microbes seem to adapt to the space environment in ways "not observed on Earth" and in ways that "can lead to increases in growth and virulence".[124] More recently, in 2017, bacteria were found to be more resistant to antibiotics and to thrive in the near-weightlessness of space.[125] Microorganisms have been observed to survive the vacuum of outer space.[126][127]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Infection is the invasion and subsequent multiplication of pathogenic microorganisms—such as , viruses, fungi, parasites, or other germs—within the tissues of a host organism, often triggering an that may manifest as symptoms or lead to . This process distinguishes infection from mere , where microbes are present without causing harm or tissue invasion. While many infections remain , particularly in healthy individuals with robust immune defenses, they can spread to others and pose significant challenges. Pathogenic agents responsible for infections vary widely in structure and behavior. , single-celled prokaryotes, can produce toxins or directly damage tissues, as seen in infections like or . Viruses, obligate intracellular parasites consisting of genetic material encased in protein, hijack host cells to replicate, causing illnesses such as or . Fungi, including yeasts and molds, typically affect immunocompromised hosts and lead to conditions like or , while parasites such as protozoa (e.g., in ) or helminths invade via vectors or contaminated sources. Only a small fraction of the myriad microbes in our environment are capable of causing infection, as most are harmless commensals or even beneficial to the host . Infections transmit through multiple routes, facilitating their global impact. Direct person-to-person spread occurs via respiratory droplets from coughing or sneezing (e.g., within about 6 feet), physical contact, or sexual activity, while indirect transmission involves contaminated surfaces, , or . Vector-borne infections, such as those carried by mosquitoes (e.g., dengue) or ticks (e.g., ), and airborne aerosolized particles enable wider dissemination. Susceptibility depends on host factors like age, immune status, , and underlying conditions; for instance, the very young, elderly, or those with from or face higher risks. Common symptoms of infection include fever, fatigue, chills, cough, diarrhea, and localized pain or swelling, reflecting the body's inflammatory response to combat the invaders. Complications can range from mild dehydration to severe sepsis, organ failure, or chronic conditions like hepatitis leading to liver cancer. Prevention strategies emphasize hygiene, such as handwashing and safe food handling, alongside vaccination, antimicrobial stewardship, and vector control to mitigate outbreaks.

Definition and Types

Definition

An infection is defined as the of an organism's body tissues by disease-causing agents, such as pathogenic microorganisms, followed by their multiplication and the host's reaction to these agents and any toxins they produce, which can lead to impaired tissue function and . This process requires specific biological prerequisites, including the pathogen's entry into the host (often through breaks in or mucosal barriers), successful replication within host cells or tissues, and the initiation of a host that may range from localized to systemic effects. Infections are distinct from , which refers to the mere presence of microorganisms on inanimate objects, and , which involves harmless presence and multiplication of microbes on or in body surfaces without penetration into tissues or harm. Similarly, involves the invasion and residence of larger parasitic organisms, such as lice or mites, on or within the host, typically without the same intracellular replication seen in microbial infections. Infections can manifest as localized, confined to a specific tissue or organ such as a skin abscess, or systemic, spreading throughout the body and potentially causing widespread dysfunction like in .

Types of Infections

Infections are classified primarily by their causative agents, which determine the nature of the disease and guide treatment approaches. These agents fall into several major categories: , viruses, fungi, , helminths (parasitic worms), and prions. Bacterial infections are caused by single-celled prokaryotes, such as species, which can lead to conditions like or . Viral infections result from viruses that replicate inside host cells, exemplified by or . Fungal infections arise from eukaryotic fungi like Candida or molds, often affecting immunocompromised individuals and causing issues such as thrush or . Parasitic infections include protozoan diseases like from species and helminthic infections like from roundworms. Prion-based infections, a rare category, involve misfolded proteins that propagate abnormally, leading to neurodegenerative diseases such as Creutzfeldt-Jakob disease. Infections can also be categorized by anatomical site or extent of involvement, highlighting their diversity in clinical presentation. Localized infections are confined to a specific area, such as urinary tract infections caused by or skin abscesses. Systemic infections spread through the bloodstream, as in , where pathogens disseminate widely and can affect multiple organs. Organ-specific infections target particular systems, including respiratory tract infections like or gastrointestinal infections such as . Certain infections defy simple categorization due to their complexity, including mixed (polymicrobial) and forms. Polymicrobial infections involve multiple microbial species acting synergistically, common in chronic wounds, , or intra-abdominal abscesses where bacteria like anaerobes and aerobes coexist. forms include acute infections, which onset suddenly and resolve quickly, versus chronic infections that persist for months or years, often due to immune evasion by agents like . Prevalence varies widely across categories, underscoring their global health impact. Bacterial infections like , caused by group A , are highly common, accounting for 20-30% of pediatric sore throats and affecting millions annually in routine clinical settings. In contrast, parasitic infections such as are rarer in non-endemic regions but remain a major burden in tropical areas, with an estimated 263 million cases worldwide in 2023, primarily in .

Pathophysiology

Microbial Colonization

Microbial represents the initial stage of microbial interaction with host surfaces, involving the attachment, proliferation, and establishment of microorganisms on mucosal or epithelial linings without immediate tissue or manifestation. This process is fundamental to both commensal relationships and the prelude to opportunistic infections, where microbes exploit host niches for survival. In healthy hosts, by normal flora maintains ecological balance, while in vulnerable individuals, it can shift toward pathogenic dominance. The primary mechanisms of begin with , facilitated by microbial structures such as pili (also known as fimbriae) and adhesins that bind to host cell receptors. For instance, type 1 pili on enable specific attachment to residues on host mucins via the adhesin FimH, while type IV pili in pathogens like species promote and close-range adherence to epithelial cells. Following , microbial growth occurs through acquisition from host secretions, often culminating in formation—structured communities encased in extracellular polymeric substances that enhance resilience against shear forces and agents. , observed in species like , allow for collective metabolism and protection during surface . Reproduction then sustains the population, with dividing in nutrient-rich microenvironments provided by the host. Normal flora, such as and species in the gut, establish symbiotic by adhering to mucosal surfaces and competing for resources, thereby preventing overgrowth by transients. In contrast, opportunistic colonizers like or Clostridium difficile typically remain benign in immunocompetent hosts but expand during , such as after disruption of the . Key factors enabling colonization include host mucosal barriers, like the layer in the , which provides a selective environment through glycans and , and microbial virulence factors such as adhesins (e.g., intimin in enteropathogenic E. coli) that confer specificity and stability to attachments. In the gut, for example, the diverse microbiome dominated by Firmicutes and Bacteroidetes colonizes via nutrient competition and pH modulation, whereas in immunocompromised hosts, such as those with , opportunistic fungi like Candida overtake normal flora due to impaired barriers. Colonization transitions toward potential infection when microbial communities overwhelm host defenses, such as through biofilm maturation or adhesion-mediated breach of epithelial integrity, setting the stage for deeper tissue involvement.

Invasion and Disease Progression

Once microbial colonization transitions to invasion, pathogens employ various mechanisms to breach host barriers and establish infection. Virulence factors such as adhesins and fimbriae enable initial attachment and tissue penetration, while enzymes like and proteases facilitate spread by degrading components. Immune evasion strategies, including capsules that inhibit —as seen in and —and IgA proteases that neutralize mucosal antibodies in pathogens like , allow microbes to avoid innate defenses. Toxin production further contributes: exotoxins, secreted proteins from bacteria such as , directly damage host cells by disrupting physiological processes like protein synthesis or nerve function, while endotoxins, lipopolysaccharides from like , trigger intense inflammatory cascades upon release during cell . The host's inflammatory response, mediated by release from activated macrophages and neutrophils, amplifies ; excessive inflammation can lead to tissue damage through collateral effects like and , even as it aims to contain the . Disease progression unfolds in distinct stages following invasion. The incubation period represents the initial phase after pathogen entry, during which microbes replicate asymptomatically within host tissues, with duration varying by agent virulence and host factors—ranging from hours in acute bacterial infections to weeks in viral ones. This is succeeded by the prodromal stage, characterized by nonspecific symptoms such as malaise, low-grade fever, and localized discomfort, arising from early innate immune activation as pathogen load increases. The acute phase then emerges with overt, pathogen-specific manifestations, including severe inflammation, tissue destruction, and systemic effects, as the adaptive immune response peaks; here, endotoxins and exotoxins play pivotal roles—endotoxins inducing fever and shock via Toll-like receptor activation, and exotoxins causing targeted cytotoxicity, as in cholera toxin-mediated fluid loss from Vibrio cholerae. Key factors influencing invasion and progression include virulence genes and bacterial communication systems. Virulence genes encode factors like invasins and secretion systems that promote intracellular entry and host cell manipulation, often clustered in pathogenicity islands for coordinated expression. , a density-dependent signaling mechanism using autoinducers such as acyl-homoserine lactones in or peptides in Gram-positive ones, regulates these genes to synchronize production—including toxins, biofilms, and motility—once a critical threshold is reached, enhancing collective invasion as observed in Pseudomonas aeruginosa lung infections. Unchecked progression can culminate in severe complications like and organ failure. Sepsis arises when the dysregulated to invading pathogens causes widespread endothelial damage and microvascular dysfunction, leading to inadequate tissue perfusion. This escalates to multiple organ failure as vital organs such as the kidneys, lungs, and heart succumb to hypoxia and inflammatory injury, with Gram-negative endotoxins often exacerbating the . is a leading worldwide, with an estimated 21.4 million sepsis-related deaths in , representing nearly one-third of all global deaths.

Transmission Pathways

Infections spread from a source to a susceptible host through various transmission pathways, which can be broadly categorized as direct or indirect. Direct transmission occurs when an infectious agent is transferred immediately from an infected individual to a susceptible host without an intermediate or vector. Indirect transmission involves an , such as a vector, , or environmental surface, facilitating the spread. These pathways are influenced by environmental factors like and , as well as behavioral factors including practices and social interactions. Direct contact transmission happens through physical touching of skin or mucous membranes between an infected person and a susceptible host. Examples include skin-to-skin contact leading to infections like infectious mononucleosis or gonorrhea. Droplet transmission, another direct mode, involves large respiratory droplets (greater than 5 microns) expelled during coughing, sneezing, or talking, which travel short distances, typically up to 1-2 meters (3-6 feet), to infect others via mucous membranes. For instance, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, spreads primarily through inhalation of respiratory droplets and aerosols from close contact. Sexual transmission represents a specialized form of direct contact, occurring through exchange of semen, vaginal fluids, or blood during vaginal, anal, or oral sex, affecting pathogens like human immunodeficiency virus (HIV) and Chlamydia trachomatis. Vertical transmission, or mother-to-child spread, is a direct pathway during pregnancy, labor, delivery, or breastfeeding, as seen with HIV and hepatitis C virus (HCV). Indirect transmission pathways encompass airborne, vector-borne, and vehicle-borne modes. involves smaller droplet nuclei (less than 5 microns) or dust particles that remain suspended in the air and travel longer distances, infecting hosts upon ; exemplifies this route. Vector-borne transmission relies on living organisms, such as insects or arachnids, to mechanically or biologically carry pathogens from one host to another. Biologic vectors, like mosquitoes transmitting parasites or blacklegged ticks () spreading , the bacterium causing , require the pathogen to replicate within the vector before transmission. Vehicle-borne transmission occurs via contaminated inanimate objects or substances, including food, water, or s (non-living surfaces like doorknobs or utensils). For example, spreads through fecal-oral contamination of food or water, while transmission, though generally low-risk for , can occur via touched surfaces harboring viable . The dynamics of infection reservoirs play a critical role in sustaining transmission pathways. Reservoirs are natural habitats where pathogens persist, including human hosts for diseases like , animal hosts for zoonotic infections such as from bats or dogs, and environmental sources like soil harboring for . Zoonotic transmission, a often involving reservoirs, accounts for a significant portion of emerging infections, with pathogens spilling over to humans through direct animal contact, vectors, or environmental exposure. Behavioral factors, such as close proximity in households or travel to endemic areas, amplify these pathways, while environmental conditions like humidity can enhance droplet or vector survival. Prevention through hygiene and measures, such as and , can interrupt these chains, though detailed strategies are addressed elsewhere.

Clinical Features

General Signs and Symptoms

Infections often manifest through local signs at the site of microbial invasion, reflecting the body's initial inflammatory response. These cardinal signs, first described by the Roman physician , include redness (rubor) due to and increased blood flow, swelling (tumor) from fluid leakage into tissues, heat (calor) resulting from heightened local circulation, and pain (dolor) caused by nerve stimulation from inflammatory mediators and pressure on surrounding structures. A fifth sign, loss of function, may also occur when impairs tissue mobility or organ performance. These local responses help contain the but can become pronounced in acute infections, such as skin abscesses where purulent drainage accompanies the signs. Systemic symptoms emerge when the infection spreads or triggers a broader immune , affecting the entire body. Common indicators include fever, arising from pyrogenic that reset the hypothalamic to elevate body temperature and inhibit replication; and malaise, stemming from energy diversion toward immune defense; and , where lymph nodes enlarge and become tender due to immune cell proliferation. Other systemic features encompass chills, sweats, increased heart and respiratory rates, and anorexia, which collectively signal the acute phase response—a coordinated hepatic production of proteins like under influence to amplify and opsonize microbes. This response, driven by pro-inflammatory such as interleukin-6 (IL-6), tumor factor-alpha (TNF-α), and interleukin-1 beta (IL-1β), forms an inflammatory cascade that recruits immune cells and modulates the host's metabolic state to combat infection. Not all infections produce noticeable symptoms; asymptomatic cases occur when the pathogen is controlled without overt clinical manifestations, allowing transmission without detection, as seen in up to 50% of certain viral infections. The , defined as the interval from pathogen entry to symptom onset, varies by agent but typically ranges from days to weeks, during which the host may remain presymptomatic and potentially infectious while the microbial load builds. These silent phases underscore the importance of immune in preventing progression, though they complicate early intervention efforts.

Differences in Bacterial and Viral Infections

Bacterial infections typically present with localized symptoms such as redness, swelling, pain, and purulent discharge at the site of infection, often accompanied by a high fever and rapid onset of illness. For example, bacterial pneumonia caused by Streptococcus pneumoniae commonly features a productive cough with purulent sputum, chest pain, and chills, allowing for effective treatment with antibiotics that target bacterial cell wall synthesis or protein production. These infections respond well to antibiotics like penicillin, which inhibit bacterial growth without affecting host cells, though antibiotic resistance poses a growing challenge. In contrast, viral infections are generally systemic and diffuse, manifesting as widespread symptoms including , , , and sometimes , accompanied by fever (often high and sudden, as in ) that typically resolves without specific antiviral intervention. , caused by influenza viruses, exemplifies this with sudden onset of high fever, chills, body aches, and respiratory symptoms that are typically self-limiting within 3–7 days, relying primarily on supportive care, as antivirals like are specific to certain viruses such as . Antiviral therapies face challenges such as viral mutation leading to resistance and the need to target intracellular replication, making them less broadly effective than antibiotics for . Overlaps between bacterial and viral infections can lead to misdiagnoses, as both may cause similar conditions like or , necessitating laboratory confirmation through cultures or molecular tests. A common complication is secondary bacterial infections following viral illnesses, where viruses like damage , facilitating bacterial superinfections such as , which significantly increases morbidity and mortality. Immune responses differ markedly: bacterial infections, particularly extracellular ones, primarily elicit with antibody production (IgM and IgG) for opsonization, neutralization of toxins, and complement activation to clear pathogens. Viral infections, however, predominantly activate , involving cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells to lyse infected host cells, alongside responses to inhibit , with antibodies playing a secondary role in limiting spread.
AspectBacterial InfectionsViral Infections
Symptom LocalizationLocalized (e.g., purulent discharge, swelling)Systemic (e.g., , diffuse )
Onset and CourseRapid onset; responds to antibioticsOften self-limiting; supportive care primary
Immune FocusHumoral (antibodies for opsonization)Cell-mediated (CTLs, NK cells for )
ExampleS. pneumoniae Influenza virus

Diagnosis

Symptomatic and Physical Evaluation

The initial symptomatic and physical evaluation of suspected relies on a thorough and clinical examination to identify potential infectious etiologies and guide further management. taking begins with assessing exposure risks, including contact with ill individuals, animal or insect bites, consumption of potentially contaminated food or water, occupational hazards, and recent sexual activity, as these factors help pinpoint likely pathogens and transmission modes. A detailed travel is essential, documenting destinations, duration, itinerary, accommodations, and activities such as trekking or freshwater exposure, particularly for travelers returning from low- and middle-income countries where diseases like malaria or dengue predominate. The timeline of symptoms is critical, encompassing onset, progression, severity, and any correlation with exposures; for instance, short incubation periods (under 14 days) suggest acute illnesses like dengue, while longer periods may indicate tuberculosis. Vaccination status, underlying comorbidities, and medication , including prophylaxis, are also reviewed to contextualize susceptibility and rule out vaccine-preventable diseases. Physical examination focuses on vital signs and targeted inspection and palpation to detect systemic or localized signs of infection. Vital signs often reveal abnormalities indicative of inflammatory response, such as fever (temperature >38°C or <36°C), tachycardia (heart rate >90 beats per minute), and (respiratory rate >20 breaths per minute), which signal potential systemic involvement. For localized infections, may show , swelling, or warmth at the site, while assesses tenderness, induration, or fluctuance, as seen in skin and soft tissue infections where these cardinal signs—redness, , , and heat—extend beyond the affected area. Additional findings include , , or organ-specific changes like in systemic cases, helping to localize the infection source. Imaging studies, such as chest X-rays for , for abscesses, or computed tomography (CT) scans for intra-abdominal infections, are often employed based on clinical suspicion to visualize and confirm infectious foci, guiding site-specific sampling or treatment. Scoring systems aid in evaluating the severity of suspected systemic infections. The (SIRS) criteria, established in , historically identified through two or more abnormalities in temperature, heart rate, respiratory rate or PaCO₂, and white blood cell count; when associated with infection, it suggested . However, due to limitations in specificity and mortality prediction, the 2016 Sepsis-3 consensus redefined as life-threatening from infection and introduced the quick Sequential Organ Failure Assessment (qSOFA) for bedside screening outside the ICU. qSOFA identifies high-risk patients with ≥2 of: respiratory rate ≥22 breaths/min, altered mentation ( ≤14), or systolic ≤100 mmHg, prompting further evaluation for using the full Sequential Organ Failure Assessment (SOFA) score. Differential diagnosis during this evaluation involves distinguishing infectious processes from non-infectious mimics through history and exam patterns. For example, fever with may stem from noninfectious causes like , autoimmune disorders, or drug reactions, necessitating consideration of symptom chronicity and absence of exposure risks to avoid misdiagnosis. Local signs such as and swelling can mimic noninflammatory conditions like or allergic reactions, where history of trauma or exposures helps differentiate. This clinical judgment often prompts subsequent microbiological confirmation for definitive identification.

Microbiological Confirmation

Microbiological confirmation involves techniques to isolate, visualize, and identify infectious pathogens from clinical specimens, providing definitive evidence of infection and guiding . These methods rely on the growth, morphological characteristics, and biochemical properties of microorganisms, typically requiring 24 to 72 hours for results, though they remain foundational due to their specificity and ability to assess antimicrobial susceptibility. Culture techniques are essential for isolating viable pathogens and determining their quantity in samples. Blood cultures, collected from two separate venipuncture sites to minimize contamination, are incubated in aerobic and anaerobic broth media at 35–37°C for up to five days; true bacteremia is suggested by growth in multiple sets, short time to positivity (e.g., <2 hours), and clinical correlation, as bacterial loads are often low (<10 CFU/mL). Urine cultures use midstream clean-catch specimens plated on selective media like blood agar or MacConkey agar, incubated overnight, where counts exceeding 10⁵ CFU/mL per species suggest urinary tract infection. Swab cultures from sites such as wounds or the throat are streaked onto appropriate agar (e.g., sheep blood agar for streptococci or chocolate agar for fastidious organisms) and incubated under specified conditions to promote growth, allowing subculture for further identification. Microscopy provides rapid preliminary identification by examining specimen morphology and staining properties. Gram staining differentiates into gram-positive (retaining crystal violet-iodine complex, appearing purple) and gram-negative (decolorized by alcohol, counterstained pink with ) based on differences, aiding in initial categorization before culture results. Acid-fast staining, using dye heated to penetrate waxy s, identifies mycobacteria like as red rods against a background after acid-alcohol decolorization, crucial for tuberculosis diagnosis. For parasitic infections, wet mount preparations of stool or tissue fluids suspend samples in saline or iodine on a slide, allowing direct observation of motile trophozoites, cysts, or eggs under low-power to detect like or helminths. Biochemical assays confirm bacterial identity by exploiting metabolic differences after initial isolation. The catalase test detects the that decomposes into water and oxygen, producing bubbles in positives like staphylococci (distinguishing them from catalase-negative streptococci), performed by adding 3% to a colony on a slide. The coagulase test identifies by its ability to clot rabbit plasma via free coagulase in a tube incubated at 37°C for 4 hours, or bound clumping factor in a slide test, essential for differentiating pathogenic from non-pathogenic staphylococci in skin or bloodstream infections. Antibiotic sensitivity testing evaluates pathogen responses to antimicrobial agents, informing treatment choices. The disk diffusion method (Kirby-Bauer) places antibiotic-impregnated disks on inoculated Mueller-Hinton agar, incubating at 35°C for 16–18 hours; inhibition zone diameters are measured and interpreted per Clinical and Laboratory Standards Institute (CLSI) breakpoints as susceptible, intermediate, or resistant. determines the (MIC) by observing growth in 96-well plates with serial antibiotic dilutions after overnight incubation, providing quantitative data for pathogens like gram-negative enteric . These tests help combat resistance by ensuring appropriate drug selection.

Molecular and Advanced Testing

Molecular and advanced testing encompasses a range of high-sensitivity techniques that detect nucleic acids, proteins, or host immune responses directly from clinical samples, enabling faster and more precise identification of infections compared to traditional methods requiring cultivation. These approaches are particularly advantageous for non-culturable or fastidious organisms, providing results within hours to days and guiding prompt therapeutic decisions. Polymerase chain reaction (PCR) amplifies specific DNA or sequences from pathogens, serving as a foundational tool in infection diagnostics since its adaptation for clinical use in the late . Real-time PCR, or quantitative PCR (qPCR), integrates amplification with fluorescence detection to monitor the process in real time, allowing quantification of viral loads essential for managing chronic infections like , where it measures copies per milliliter of blood to evaluate antiretroviral therapy efficacy. For instance, real-time reverse transcription PCR (RT-PCR) detects and quantifies viruses such as , correlating cycle threshold values with infectious viral burden to inform isolation protocols. Multiplex PCR variants further enhance efficiency by simultaneously targeting multiple pathogens in one reaction, ideal for syndromic panels in respiratory or bloodstream infections; clinical studies demonstrate that multiplex real-time PCR identifies bacterial and fungal agents in with sensitivities exceeding 80% and reduces diagnostic turnaround time by up to 40% compared to conventional testing. Metagenomic next-generation sequencing (mNGS) represents an unbiased, culture-independent method that sequences all microbial genetic material in a sample, enabling discovery of unknown or rare without targeted primers. This technique is especially impactful in complex cases like or infections in immunocompromised hosts, where it broadens the pathogen detection spectrum to include viruses, , fungi, and parasites simultaneously. For example, mNGS has identified novel agents in outbreaks and improved etiological diagnosis in 30-50% of culture-negative cases by analyzing fluid. Despite its high sensitivity, mNGS requires bioinformatics pipelines to distinguish pathogens from host or contaminant sequences, and its clinical is supported by studies showing positive predictive values around 60-70% for presumed infections. Serological assays detect host antibodies or pathogen antigens indicative of current or past infection, complementing tests by identifying immune responses. The enzyme-linked immunosorbent assay () is a cornerstone serologic method, using immobilized antigens to capture and quantify antibodies via enzymatic color change; for , it sensitively detects IgG/IgM antibodies and p24 antigen, with fourth-generation ELISAs reducing the diagnostic window to 13-42 days post-exposure. These assays achieve specificities over 99% in low-prevalence settings when confirmed by , though false positives necessitate follow-up testing. Point-of-care (POC) tests deliver rapid results using portable devices, minimizing laboratory dependency and enabling immediate clinical action. Lateral flow antigen tests for and detect viral nucleoproteins in nasopharyngeal swabs within 15-30 minutes, with sensitivities of 70-90% for high-viral-load samples and specificities near 100%. Multiplex POC panels, such as those combining , A, and B detection, facilitate during co-circulation seasons, as validated in evaluations showing comparable performance to laboratory PCR for symptomatic patients.

Classification

By Clinical Course

Infections are classified by clinical course based on their progression, manifestation, and duration, which informs , transmission risk, and strategies. This approach distinguishes how infections evolve in the host, from silent persistence to overt , and highlights differences in resolution or persistence that affect interventions. Such classifications emphasize the dynamic interplay between and host immunity, rather than the etiological agent itself. Subclinical or latent infections occur without noticeable symptoms, yet the remains viable and may lead to transmission or later disease. In these cases, the host's controls replication without causing apparent illness, allowing asymptomatic carriers to unknowingly spread the infection. For instance, in caused by Salmonella Typhi, up to 5% of individuals become chronic carriers who excrete the bacteria in feces for over a year, facilitating ongoing transmission without fever or gastrointestinal symptoms. This contrasts with clinical or apparent infections, where symptoms emerge due to sufficient pathogen load or immune activation, such as fever, pain, or , making the condition diagnosable through patient presentation. Acute infections develop rapidly, peak in severity, and typically resolve within weeks to months through immune clearance or attenuation. The common virus exemplifies this, with symptoms like high fever and respiratory distress appearing 1-4 days post-exposure and resolving in 7-10 days for most immunocompetent individuals, though complications can prolong recovery. In contrast, chronic infections persist for months to years, often evading full immune elimination and leading to tissue damage over time. infection illustrates this, where acute phase symptoms resolve in 15-45% of cases, but the remainder progress to chronicity, with liver developing in 20-30% of untreated patients over 20 years. The distinction aids in anticipating long-term sequelae, as chronic forms like hepatitis C increase risks of and . Primary infections affect healthy, immunocompetent hosts, manifesting as the initial encounter with a and often eliciting a robust . These differ from opportunistic infections, which primarily arise in immunocompromised individuals, such as those with or undergoing , where normally commensal or low-virulence microbes exploit weakened defenses. For example, pneumonia is rare in healthy adults but a leading cause of death in AIDS patients with counts below 200 cells/μL, progressing rapidly due to impaired T-cell immunity. This host-dependent progression underscores how clinical course varies by immune status, with opportunistic cases often showing atypical severity or dissemination. Contagiousness in infections is tied to the clinical course, particularly through phases like incubation ( replication) and shedding (active release of infectious particles). During incubation, individuals are typically non-contagious, but pre-symptomatic shedding can occur, as seen in where viral loads peak 2-3 days before symptoms, enabling transmission up to 40% of cases. In chronic or latent infections, prolonged shedding periods heighten community spread; for example, in , latent carriers harbor without symptoms but can reactivate and become contagious later in life, with 5-10% lifetime risk in immunocompetent hosts. These temporal dynamics guide isolation protocols and to mitigate outbreaks.

By Causative Agent and Location

Infections are classified by their causative agents, which include viruses, , fungi, , and helminths, each capable of targeting specific body sites to produce distinct clinical manifestations. Viral infections, such as those caused by immunodeficiency virus (), often lead to systemic involvement affecting multiple organs including the , while bacterial infections like tuberculosis () caused by primarily target the respiratory tract. Fungal infections, exemplified by from Candida , commonly affect mucosal surfaces such as the oral cavity, , or , though they can disseminate in immunocompromised individuals. Protozoal infections, such as from , invade erythrocytes and can affect the liver and , while helminthic infections like from typically reside in the . Classification by body location further refines understanding, as pathogens exploit specific anatomical vulnerabilities. Respiratory infections encompass upper tract conditions like viral common colds caused by rhinoviruses or bacterial pharyngitis from Streptococcus pyogenes, and lower tract diseases such as bacterial pneumonia from Streptococcus pneumoniae or viral bronchiolitis from respiratory syncytial virus (RSV). Gastrointestinal infections often manifest as diarrhea; bacterial examples include cholera from Vibrio cholerae affecting the small intestine, while viral causes like norovirus or rotavirus target the gut epithelium in outbreaks. Central nervous system (CNS) infections, such as bacterial meningitis from Neisseria meningitidis or viral meningitis from enteroviruses, involve the meninges or brain parenchyma, leading to inflammation and potential neurological sequelae. Distinctions between nosocomial (hospital-acquired) and community-acquired infections highlight acquisition contexts, influencing pathogen profiles and management. Community-acquired infections occur outside healthcare settings and present at or within 48 hours of admission, often involving less resistant organisms like Streptococcus pneumoniae in pneumonia. Nosocomial infections develop 48 hours or more after admission or post-discharge, commonly linked to invasive devices and multidrug-resistant pathogens, with examples including ventilator-associated pneumonia from gram-negative bacilli or catheter-associated urinary tract infections from Escherichia coli. Zoonotic infections, transmitted from animals to humans, are categorized similarly by agent and site, posing risks through direct or indirect contact. Viral zoonoses include affecting the CNS via animal bites and targeting the from exposure. Bacterial examples encompass from species causing gastrointestinal illness via contaminated food and from leading to skin and joint involvement through tick bites. Parasitic zoonoses like toxoplasmosis from can involve the CNS in immunocompromised hosts, often from cat feces exposure.

By Infectivity and Opportunism

Infections are classified based on their , which refers to the capacity of a to transmit from one host to another, and , which describes the pathogen's ability to cause primarily in hosts with compromised defenses. This classification highlights how pathogens interact with host immunity and environmental factors to establish , independent of the specific causative agent or anatomical site. Infectivity is influenced by the pathogen's survival outside the host and its transmission mechanisms, while opportunism underscores the role of host vulnerability in disease manifestation. Infectious diseases are caused by viable pathogens capable of transmission between hosts, often persisting in the environment or through direct contact, vectors, or droplets. Non-infectious conditions, by contrast, mimic infection symptoms but lack transmissible pathogens; these include inflammatory responses or toxic exposures where no viable microorganism can propagate outside the host. For instance, bacterial pathogens like remain viable in aerosols for hours, facilitating airborne spread, whereas non-infectious mimics such as sterile abscesses do not involve pathogen replication or transmission. Opportunistic infections occur when normally commensal or low-virulence microorganisms exploit a weakened host to cause , rather than actively invading healthy individuals. These are prevalent in conditions like , where Pneumocystis jirovecii emerges due to T-cell depletion, transforming a ubiquitous into a lethal in immunocompromised patients. Unlike primary infections, opportunistic ones rarely transmit between hosts because the pathogen's success depends on host-specific vulnerabilities, such as from or . Host susceptibility factors, such as genetic defects in immune signaling, can further predispose individuals to these infections. Infections are further categorized by source as endogenous or exogenous. Endogenous infections arise from the patient's own microbial flora, often translocating from sites like the gut or skin to sterile areas during breaches in barriers, such as surgical wounds leading to Clostridium difficile colitis in antibiotic-disrupted microbiomes. Exogenous infections, conversely, stem from external pathogens introduced via contaminated environments, medical devices, or person-to-person contact, exemplified by hospital-acquired Staphylococcus aureus infections from unsterile equipment. This distinction aids in prevention strategies, emphasizing endogenous control through microbiome preservation and exogenous measures like sterilization.) Virulence factors are molecular determinants that enhance a 's by promoting , invasion, toxin production, or immune evasion, thereby increasing transmission potential and disease severity. For example, bacterial adhesins like fimbriae enable to colonize urinary tracts and facilitate fecal-oral spread, while viral envelope proteins in allow cell entry and antigenic drift for sustained . These factors evolve under selective pressure, balancing replication efficiency with host survival to maximize transmission; in , for instance, coordinates virulence gene expression only at high densities, optimizing in crowded host niches. Seminal studies on virulence highlight how exotoxins and biofilms contribute to chronic infections in vulnerable hosts, underscoring the interplay between pathogen armament and host defenses.

Prevention Strategies

Hygiene and Public Health Measures

measures, such as regular handwashing with and water, represent a foundational strategy for interrupting the transmission of infectious agents at the individual level. Handwashing can prevent approximately 30% of diarrhea-related illnesses and 20% of respiratory infections by removing pathogens from the skin before they spread to others or enter the body. In healthcare settings, adherence to hand protocols has been shown to reduce healthcare-associated infections by up to 50%, underscoring its role in protecting vulnerable populations. Sanitation infrastructure complements personal hygiene by addressing environmental transmission routes, particularly for waterborne and fecal-oral pathogens. Access to facilities, including proper disposal and latrines, prevents contamination of water sources and reduces the incidence of diseases like typhoid and . The emphasizes that integrating water, , and hygiene () interventions in communities can avert up to 1.4 million deaths annually from diarrheal diseases, with handwashing alone potentially preventing 25% of such episodes. Quarantine protocols involve isolating individuals who have been exposed to or infected with a contagious to limit community spread, a practice refined since the for plagues and proven effective in modern outbreaks. During the , case isolation combined with of contacts reduced transmission by 40-60% in modeled scenarios, particularly when implemented early. These measures are most impactful for diseases with moderate asymptomatic transmission periods, such as or , where durations of 7-14 days balance efficacy with feasibility. Vaccination programs form a of efforts to achieve , where a sufficient proportion of the population is to protect unvaccinated individuals by curtailing outbreaks. Herd immunity thresholds vary by ; for , a vaccination coverage of 95% is required due to its high transmissibility, while needs around 80%. Successful campaigns, like those eradicating through the Expanded Programme on Immunization, demonstrate how sustained vaccination drives can eliminate diseases by surpassing these thresholds. Surveillance systems, including and outbreak monitoring, enable rapid detection and containment of infections to prevent escalation. identifies and monitors exposed individuals, breaking transmission chains and averting secondary cases; for instance, during outbreaks, it reduced further infections by up to 80% when integrated with . Tools like digital platforms for real-time data entry enhance these efforts, allowing health authorities to coordinate responses and allocate resources efficiently in diverse settings. A practical example of these measures is water treatment for cholera prevention, where chlorination or filtration of drinking water sources has dramatically curbed epidemics. In outbreak settings, adding chlorine-based disinfectants to household water reduces Vibrio cholerae viability, significantly reducing the number of cases when combined with sanitation improvements. Historical interventions, such as those during the 19th-century London cholera outbreaks, established water purification as a model for controlling waterborne diseases globally.

Immunological Defenses

The provides the first line of defense against infections through physical and chemical barriers that prevent entry. The skin serves as a primary physical barrier, consisting of tightly linked connected by desmosomes, which block microbial invasion, while also producing such as and cathelicidins via receptors. Mucosal surfaces in the respiratory, digestive, and genitourinary tracts form continuous epithelia lined with and cilia that trap and expel pathogens, further enhanced by and cytokines like IL-1 and TNF-α. These barriers are nonspecific and act immediately upon exposure, minimizing the establishment of infection without prior . If pathogens breach these barriers, innate immune cells such as —primarily neutrophils and macrophages—engulf and destroy invaders through , forming as a byproduct of dead cells and . The , a group of plasma proteins, amplifies this response by opsonizing pathogens to facilitate , recruiting inflammatory cells, and directly lysing microbes via the membrane attack complex, thereby providing rapid, broad-spectrum protection against and viruses. These mechanisms are evolutionarily conserved and effective against common pathogens, often resolving infections before adaptive responses are fully engaged. The offers pathogen-specific defenses, with the humoral response mediated by B lymphocytes that differentiate into plasma cells secreting antibodies. These antibodies neutralize toxins and pathogens by binding to antigens, preventing cellular entry, and marking targets for destruction through opsonization or complement activation. In parallel, the cellular response involves T lymphocytes, including helper T cells (+) that secrete cytokines to coordinate immunity and cytotoxic T cells (+) that directly eliminate infected cells by inducing . This targeted action limits intracellular pathogens like viruses, contrasting with the innate system's generality. A hallmark of adaptive immunity is immunological memory, where antigen-specific B and T cells persist long-term after initial exposure, enabling faster and more robust secondary responses upon re-challenge. Memory B cells rapidly produce high-affinity antibodies, while memory T cells proliferate into effectors without needing innate priming, conferring lasting protection against reinfection. This memory formation underpins vaccines, which mimic natural infection by introducing antigens—such as weakened pathogens or protein fragments—to stimulate antibody production and memory cell generation without causing disease. For instance, live-attenuated vaccines replicate mildly to enhance responses, leading to lifelong immunity in many cases, while inactivated versions require boosters to maintain memory. Genetic variations in (HLA) genes modulate these immune responses by influencing to T cells. HLA class I molecules, like those encoded by HLA-B, display viral or bacterial peptides on cell surfaces, enabling cytotoxic T-cell recognition; certain alleles, such as HLA-B27 and HLA-B57, enhance control of by targeting conserved epitopes, delaying progression, whereas HLA-B35 accelerates it. Similarly, HLA-B53 protects against severe by improving peptide presentation for immune activation. These polymorphisms affect susceptibility across infections, with protective alleles promoting efficient T-cell responses and others impairing clearance, as seen in hepatitis C where HLA class II variants like DRB1*1301 aid viral elimination.

Host Susceptibility Factors

Host susceptibility to refers to the inherent or acquired characteristics of an individual that influence their vulnerability to pathogenic invasion and disease progression. These factors can modulate the likelihood of by altering barriers to entry, immune responsiveness, or tissue integrity, often interacting with environmental exposures. Understanding these elements is crucial for identifying at-risk populations and tailoring preventive measures, as susceptibility varies widely across demographics and health statuses. Genetic factors play a pivotal role in determining infection risk, with inherited immunodeficiencies exemplifying heightened vulnerability. (SCID), a group of rare genetic disorders impairing both T- and B-cell function, leads to profound susceptibility to opportunistic infections from , viruses, and fungi, often manifesting in infancy without early intervention. Age-related genetic and physiological changes further amplify risk; infants possess immature immune systems with reduced antibody production and thymic output, increasing susceptibility to pathogens like , while elderly individuals experience , characterized by declining T-cell diversity and chronic low-grade inflammation, elevating risks for infections such as and . Acquired conditions also significantly enhance infection susceptibility by compromising host defenses. Malnutrition, particularly deficiencies in protein, zinc, or vitamin A, impairs mucosal integrity and immune cell function, doubling the risk of severe infections like diarrhea in children in low-resource settings. Chronic diseases such as diabetes mellitus disrupt immune signaling and wound healing, increasing susceptibility to skin and urinary tract infections by up to threefold due to hyperglycemia fostering bacterial growth. Immunosuppression from treatments like chemotherapy for cancer depletes white blood cells, rendering patients highly vulnerable to bacterial sepsis and viral reactivations, with neutropenia alone associated with a 10-20% infection rate during treatment cycles. Behavioral factors contribute to susceptibility by directly exposing vulnerable tissues or systemically weakening immunity. Smoking introduces toxins that damage and impair ciliary clearance, increasing the risk of exacerbations from bacterial pathogens by 2-4 times compared to non-smokers. Intravenous drug use compromises skin barriers and introduces contaminants, heightening risks for bloodstream infections like from , with incidence rates of approximately 2-7 cases per 1,000 person-years among users. A notable genetic-behavioral interaction is observed in susceptibility, where individuals homozygous for the CCR5-Δ32 exhibit resistance to R5-tropic strains due to impaired viral entry into + cells, reducing infection risk in exposed populations.

Treatment Approaches

Antimicrobial Agents

Antimicrobial agents encompass a diverse array of pharmacological compounds that directly target infectious pathogens to halt their replication or survival, forming the cornerstone of infection treatment. Among these, antibiotics are primarily directed against , exploiting differences in prokaryotic cell structure and metabolism compared to eukaryotic hosts. Beta-lactam antibiotics, including penicillins and cephalosporins, exert their bactericidal effect by irreversibly binding to penicillin-binding proteins (PBPs), enzymes crucial for the final stages of cross-linking in the bacterial cell wall, leading to osmotic instability and cell lysis. In contrast, antibiotics such as erythromycin and bind to the 50S subunit of the bacterial ribosome's peptidyl transferase center, blocking the translocation step in protein synthesis and thereby inhibiting bacterial growth, typically in a bacteriostatic manner. The distinction between bactericidal and bacteriostatic antibiotics hinges on their impact: bactericidal agents actively kill by disrupting essential processes like integrity, while bacteriostatic ones merely arrest multiplication, relying on the host's for clearance. Clinical evidence indicates that this has limited practical significance in most infections, as both classes achieve comparable when dosed appropriately, though bactericidal agents may be preferred in scenarios like where rapid killing is critical. can guide selection by identifying the causative and its susceptibility profile. Antiviral agents face inherent challenges due to viruses' intracellular and structural similarities to host cellular components, restricting targets to virus-specific enzymes while minimizing host toxicity. Nucleoside analogs like acyclovir exemplify this approach; as a guanosine mimic, acyclovir is selectively phosphorylated by viral into its active triphosphate form, which then competitively inhibits viral and causes chain termination during , effectively curbing replication. This selectivity arises from viruses' dependence on hijacked host machinery, limiting broad-spectrum options and necessitating pathogen-specific therapies to avoid off-target effects on human . For fungal infections, azole antifungals such as and target the enzyme lanosterol 14α-demethylase, inhibiting the conversion of to , a vital in fungal cell membranes that maintains fluidity and integrity. This disruption depletes levels, accumulates toxic intermediates, and compromises membrane function, leading to fungal . Antiparasitic agents like , derived from , address protozoan infections such as through a unique endoperoxide bridge that, upon activation by intraparasitic iron, generates carbon-centered free radicals and , which alkylate parasite proteins, , and , causing rapid oxidative damage and parasite clearance. A pressing concern with agents is the emergence of resistance, which undermines therapeutic efficacy and poses a threat. One prominent mechanism involves β-lactamase enzymes produced by resistant bacteria, such as extended-spectrum β-lactamases (ESBLs) in , which hydrolyze the β-lactam ring core of antibiotics like penicillins and cephalosporins, rendering them inactive before they can bind PBPs. To mitigate resistance, antimicrobial stewardship programs emphasize core principles including leadership commitment to optimal use, accountability for monitoring outcomes, timely interventions like based on results, and to promote judicious prescribing, thereby preserving agent effectiveness.

Supportive and Adjunctive Therapies

Supportive therapies in management focus on maintaining physiological stability, alleviating symptoms, and preventing complications, thereby enhancing the host's ability to combat the without directly targeting the . These interventions are particularly crucial in severe cases where the body's inflammatory response can lead to . For instance, intravenous fluid administration is a cornerstone of care in systemic infections like , helping to restore intravascular volume and improve tissue , which is associated with reduced mortality when initiated early. relief measures, such as acetaminophen or nonsteroidal drugs, are routinely employed to manage fever and discomfort associated with infections, improving patient comfort and compliance with treatment. is indicated for patients with due to or secondary to infection, aiming to maintain above 92% to support vital organ function. In localized infections, surgical interventions play a vital role in adjunctive by physically removing infectious material. Drainage of abscesses, for example, is essential in conditions like staphylococcal infections or intra-abdominal abscesses, where accumulation hinders penetration and perpetuates ; timely can resolve symptoms in over 80% of cases without further escalation. Isolation protocols are implemented for highly contagious infections, such as those caused by or viral pathogens like , to prevent nosocomial spread; contact or droplet precautions in healthcare settings have been shown to reduce transmission rates by 50-70%. Probiotics are increasingly used as an adjunctive measure to restore disrupted by broad-spectrum s, which can lead to and secondary infections like . Meta-analyses indicate that supplementation during and after therapy reduces the risk of -associated by 51% and C. difficile infection by 64%. For immunocompromised patients with severe infections, intravenous immunoglobulin (IVIG) provides by supplying antibodies that bolster the host's defenses, particularly in conditions like streptococcal ; clinical studies suggest IVIG adjunct to may reduce mortality. These therapies are tailored to the patient's clinical status and integrated with treatments to optimize outcomes.

Epidemiology

Global Burden and Patterns

Infectious diseases remain a major contributor to global morbidity and mortality, accounting for approximately 28% of the total global burden of disease as measured by disability-adjusted life years (DALYs) in 2019. The temporarily increased this burden, with ranking as the second leading cause of death in 2021 (8.8 million deaths). Lower respiratory infections, , and are among the leading causes, with lower respiratory infections alone causing 2.5 million deaths in 2021, making them the fifth leading cause of death worldwide. contributed 65.1 million DALYs, 53.6 million DALYs, and a substantial share, highlighting their outsized impact on health loss, particularly through premature mortality and long-term disability. These figures underscore the persistent scale of infectious diseases, even as noncommunicable diseases dominate in high-income settings. Regional patterns reveal stark disparities, with low- and middle-income countries bearing the heaviest burden due to limited healthcare access, poor , and environmental factors. In low-income countries, communicable diseases comprise eight of the top ten causes of death, including lower respiratory infections as the leading killer, followed by , , , and diarrhoeal diseases. Tropical and subtropical regions, particularly and , see elevated rates of vector-borne diseases like and dengue, while hospital-acquired (nosocomial) infections are more prevalent in healthcare settings globally, affecting an estimated 100-200 million patients annually; of these, antibiotic-resistant cases number about 136 million. In contrast, high-income regions experience lower overall infectious disease mortality but face rising challenges from nosocomial infections in hospitals. The economic costs of infectious diseases are immense, encompassing direct healthcare expenditures, lost , and broader societal impacts, with epidemics alone estimated at $60 billion annually prior to the era. Antibiotic-resistant infections exacerbate this, imposing hospital costs of around $693 billion globally in recent estimates. Trends show declines in burden from key infections due to programs—for instance, diarrhoeal diseases and deaths have dropped by over 45% and 61% since 2000, respectively—yet rises in threaten reversals, with projections of nearly 40 million additional deaths by 2050 if unchecked. These patterns emphasize the need for targeted interventions to address disparities and emerging threats.

Historical Pandemics

The , occurring between 1347 and 1351, was a devastating caused by the bacterium , primarily spread through fleas on black rats, leading to bubonic, septicemic, and pneumonic forms of plague. It ravaged , , and , with mortality estimates indicating that 30-60% of Europe's population—approximately 25-50 million people—perished during this period. The outbreak profoundly disrupted medieval society, causing labor shortages, economic upheaval, and social unrest, while accelerating changes in feudal structures and practices. The 1918 , caused by an H1N1 influenza A virus, emerged in the spring of that year and spread globally, infecting about one-third of the world's population. It resulted in an estimated 50 million deaths worldwide, with unusually high mortality among young adults due to a severe response. The overwhelmed healthcare systems, exacerbated by troop movements, and highlighted the need for improved surveillance and medical interventions, though contemporary vaccines proved ineffective as the viral etiology was not fully understood until later. Since the early 1980s, the pandemic, triggered by the human virus (), has spread globally through blood, sexual contact, and perinatal transmission, leading to the acquired (AIDS) in untreated cases. As of 2024, approximately 44.1 million people have died from AIDS-related illnesses since the epidemic's onset, reshaping policies, stigma around sexual health, and international aid efforts. These historical pandemics underscored the importance of containment measures, with the inspiring the origins of —initially a 40-day isolation period enforced in in to curb plague spread. The and epidemics spurred advancements in and antiviral development, respectively, laying foundations for modern and targeted therapies that mitigate future outbreaks.

Emerging and Zoonotic Diseases

Emerging infectious diseases are those that have newly appeared in a or have existed but are rapidly increasing in incidence or geographic range, often originating from zoonotic sources where pathogens spill over from animals to humans. Zoonotic infections account for a significant proportion of these threats, with approximately 75% of emerging pathogens deriving from animal reservoirs. virus disease exemplifies this, as African fruit bats are believed to serve as the natural reservoir, facilitating spillover events through human contact with infected wildlife or in . Similarly, severe acute respiratory syndrome coronavirus 2 (), the causative agent of , has been traced to bat coronaviruses, particularly those in horseshoe bats (Rhinolophus species), with genetic analyses indicating a close phylogenetic relationship to bat-derived sarbecoviruses. Several anthropogenic factors drive the emergence of these zoonoses by increasing opportunities for pathogen spillover. Deforestation and habitat fragmentation bring humans into closer contact with wildlife reservoirs, amplifying transmission risks for diseases like Ebola and other filoviruses. Global travel accelerates the dissemination of emerging pathogens across borders, as seen in the rapid international spread of zoonotic agents following initial spillovers. Climate change further exacerbates this by altering vector distributions, host ranges, and environmental conditions that favor pathogen survival and transmission, potentially expanding the geographic footprint of bat-borne viruses. These interconnected drivers underscore the need for integrated environmental and health monitoring to mitigate risks. Recent outbreaks highlight the ongoing threat of zoonotic emergence. The , which began in late 2019 and continued through 2025, originated as a zoonotic event likely involving an intermediate host before widespread human-to-human transmission, resulting in over 775 million confirmed cases and more than 7 million confirmed deaths as of late 2025. The 2022 (formerly monkeypox) outbreaks, caused by clade IIb , marked a shift from its traditional zoonotic pattern in Central and West African rainforests—where and serve as reservoirs—to sustained human transmission globally, with over 100,000 cases reported across more than 100 countries by 2025, primarily through close contact. These events illustrate how zoonotic pathogens can evolve into major crises when environmental and social factors converge. Effective surveillance is crucial for early detection and response to these threats. The (WHO) operates global alert and response systems, such as the Global Outbreak Alert and Response Network (GOARN), to coordinate rapid information sharing and investigations into potential emerging events. Complementing this is the approach, which integrates human, animal, and environmental health surveillance to address zoonotic risks holistically, as endorsed by WHO and partners like the Food and Agriculture Organization (FAO). This framework has informed responses to outbreaks like and by emphasizing cross-sectoral collaboration to prevent future spillovers.

Historical and Societal Context

Development of Germ Theory

The development of germ theory marked a profound shift in understanding infectious diseases, moving away from the prevailing —which attributed illness to "bad air" or environmental vapors—and the idea of , which posited that microorganisms arose spontaneously from decaying matter. This change began in the late with the invention of , enabling direct observation of tiny life forms previously invisible to the . , a Dutch draper and self-taught microscopist, constructed simple single-lens microscopes in the 1670s and became the first to describe microorganisms, including and , in samples from his own mouth, pond water, and . His detailed letters to the Royal Society, starting in 1674, reported observations of "animalcules" in various environments, laying foundational evidence for the existence of a microbial world without linking them explicitly to disease causation. By the mid-19th century, scientific inquiry intensified against , with Louis Pasteur's experiments in the 1860s providing decisive proof that microorganisms did not arise de novo but were airborne contaminants. Pasteur's swan-neck flask experiments demonstrated that boiled remained sterile if protected from dust-borne microbes, but spoiled upon exposure, directly refuting the and supporting contagion via specific germs. Building on this, advanced the causal link between microbes and disease through rigorous isolation techniques in the 1870s and 1880s. Koch's work on anthrax in 1876 involved culturing the bacterium in pure form on media, injecting it into animals to reproduce the disease, and re-isolating the same microbe—establishing the first clear evidence of microbial etiology. He formalized these methods in 1884 as , criteria requiring the isolation of a specific from diseased hosts, its cultivation in pure culture, reproduction of disease upon inoculation into healthy hosts, and re-isolation of the identical . Koch's innovations, including the use of solid media for growing isolated bacterial colonies, revolutionized by enabling precise identification of disease-causing agents. These theoretical advances quickly translated into practical milestones that validated germ theory and reduced mortality. In 1885, Pasteur achieved a breakthrough with the first successful , administering a series of attenuated virus doses to a boy bitten by a , preventing the disease's fatal onset and demonstrating against a microbial . Concurrently, applied germ theory to in 1867, inspired by Pasteur's findings on microbial contamination. Lister introduced carbolic acid (phenol) as an to sterilize wounds, instruments, and operating environments, dramatically lowering postoperative infection rates; for instance, compound fracture mortality at dropped from 45% pre-1867 to under 15% afterward. This antisepsis system proved contagion's role in surgical infections, solidifying germ theory's impact on medical practice and paving the way for modern aseptic techniques.

Medical Specialties Involved

Infectious disease medicine is a of dedicated to the , treatment, and prevention of infections caused by bacteria, viruses, fungi, parasites, and other pathogens, particularly in complex or immunocompromised cases. Infectious disease specialists often manage challenging scenarios such as hospital-acquired infections, , and multidrug-resistant organisms, collaborating with providers to optimize therapy and reduce transmission risks. Several related medical fields play essential roles in comprehensive infection . Clinical microbiology focuses on identification and susceptibility testing of pathogens, enabling accurate diagnosis and guiding targeted treatments through techniques like culture, PCR, and . addresses outbreak investigation, surveillance, and population-level control measures, applying statistical methods to track patterns and implement interventions like and campaigns. examines the host's immune response to infections, informing strategies for , development, and management of immunodeficiencies that exacerbate susceptibility. Within infectious diseases, subspecialties address specific populations and contexts. Pediatric infectious disease specialists handle infections unique to children, such as congenital infections and vaccine-preventable diseases, tailoring therapies to developmental stages. Travel medicine experts provide pre- and post-travel consultations, advising on prophylaxis, vaccinations, and management of tropical or imported infections like and dengue. Training for infectious disease specialists typically begins with a three-year residency in (or for pediatric subspecialists), followed by a two- to three-year accredited fellowship emphasizing clinical rotations, research, and antimicrobial stewardship. is granted by bodies like the (ABIM) upon passing a rigorous examination, demonstrating expertise in infection control and emerging threats. Management often involves multidisciplinary teams, including pharmacists, nurses, and surgeons, to integrate expertise in selection, patient monitoring, and surgical interventions for source control.

Societal and Cultural Impacts

Infections have profoundly shaped societal structures through stigma, often leading to isolation and against affected individuals. Historically, was viewed as a divine curse, resulting in compulsory isolation practices that segregated patients from communities, as seen in 19th- and early 20th-century policies in places like Hawai'i, where ethical lapses in enforcement exacerbated social exile. This stigma persists at multiple levels—self-perceived by patients, familial, and communal—hindering disease elimination efforts and reinforcing social inequalities. Similarly, has triggered widespread , associating the condition with moral failing and leading to family shame, disrupted relationships, and barriers to healthcare access, with social forces like and amplifying vulnerability. Such stigma not only worsens physical and psychological outcomes but also perpetuates economic marginalization for those infected. Public policies responding to infections reflect efforts to balance with societal welfare, often imposing significant restrictions. During the , lockdowns enacted globally led to widespread lifestyle disruptions, including reduced social interactions, economic hardships, and heightened psychological distress, particularly among vulnerable groups. These measures, while aimed at curbing transmission, exacerbated inequalities in access to food, healthcare, and employment. To address —a growing threat from infectious diseases—regulatory frameworks like the U.S. National for Combating Antibiotic-Resistant (2020-2025) promote programs that optimize use through evidence-based prescribing guidelines and veterinary oversight. Internationally, the Organization's Global on , adopted in 2015 and currently under update as of 2025 with adoption expected in 2026, coordinates policies to preserve drug efficacy, emphasizing surveillance and infection prevention across sectors. Cultural representations of infections have long served as mirrors to societal fears and resilience, embedding plagues in literature and art. Daniel Defoe's A Journal of the Plague Year (1722), a semi-fictional account of the 1665 London bubonic plague, vividly captures urban panic, quarantine measures, and moral reckonings, influencing perceptions of epidemics as collective trials. In , medieval and depictions, such as the Danse Macabre motifs following the , portrayed death as an equalizer, reflecting trauma through skeletal figures leading all classes in dance amid widespread mortality. Later works, including 19th-century paintings of as a romanticized affliction of the poor, evolved to highlight poverty's role in disease, underscoring shifting cultural attitudes from supernatural punishment to social critique. These artistic narratives often precede or parallel real outbreaks, fostering public discourse on vulnerability and human endurance. Infections have driven lasting economic and societal transformations, notably accelerating remote work norms post-COVID-19. The pandemic's forced shift to remote arrangements disrupted traditional office cultures, with over half of workers facing added digital costs but gaining flexibility, leading to preferences for hybrid models that persist in many sectors. This evolution has reshaped labor markets, enhancing work-life balance for some while widening divides in access to technology and for others, signaling a broader toward decentralized economies.

Evolutionary and Extraterrestrial Aspects

Fossil Evidence of Infections

Paleopathological evidence provides critical insights into ancient infections through the study of skeletal and mummified remains, revealing how diseases manifested in prehistoric populations. Common indicators include lesions such as periosteal reactions, lytic destruction, and proliferative changes, which signal chronic infections like treponematoses. For instance, unmistakable skeletal lesions diagnostic of treponemal disease, including caries sicca on the skull and tibia, have been identified in pre-Columbian remains across the , confirming the presence of non-venereal forms such as or bejel millennia before European contact. Ancient pathogens like have left detectable traces in Egyptian mummies dating to the predynastic period around 4500–3000 BCE. At sites like Nagada in , 13 cases of skeletal lesions consistent with , such as vertebral collapse and endocranial new bone formation, indicate recurrent infections during this era. These findings, corroborated by molecular analyses, demonstrate that was established in human populations well before the Dynastic period. Modern methods enhance the detection of these ancient infections, with computed tomography (CT) scans allowing non-invasive visualization of internal bone structures and hidden pathologies in mummified tissues. () extraction, often from teeth or dense cortical bone, enables the identification of pathogen-specific sequences, such as the IS6110 insertion element for M. tuberculosis, even in cases without overt skeletal changes. These techniques, including polymerase chain reaction (PCR) and next-generation sequencing, help overcome DNA degradation and contamination challenges inherent to archaeological samples. Fossil evidence also illuminates the co-evolution of hosts and microbes, as seen in the long-term association between Homo sapiens and the * (MTBC). Ancient DNA from human remains, including strains in Egyptian mummies around 4000 years ago, reveals phylogeographical structure in MTBC lineages, suggesting local adaptation and co-divergence with human migrations over tens of thousands of years. This co-evolutionary dynamic underscores how pathogens like have shaped human immune responses and throughout .

Infections in Outer Space

Spaceflight environments pose unique challenges to human health due to the combined effects of microgravity, , and confinement, which can suppress the and increase susceptibility to infections among astronauts. Microgravity alters immune cell function, including reduced T-cell and proliferation, leading to impaired clearance and a higher risk of viral reactivation, such as herpesviruses causing cold sores or . further exacerbates this by inducing chronic inflammation and disrupting immune , while stressors like disrupted contribute to overall immune dysregulation. Studies on the (ISS) have documented these changes through monitoring of blood, saliva, and urine samples, revealing that up to 61% of astronauts experience viral reactivation during missions. Crew quarters and spacecraft surfaces present additional infection risks through microbial contamination, as enclosed habitats facilitate the spread of pathogens from crew members, food supplies, and personal items. Pathogens such as Staphylococcus aureus and Klebsiella pneumoniae have been isolated on the ISS, where biofilms—protective microbial communities—form more readily on surfaces, enhancing persistence and resistance to cleaning. Microgravity promotes bacterial proliferation by shortening the lag phase in growth cycles and increasing stationary-phase densities, while also boosting virulence in certain species; for instance, Aspergillus fumigatus and Serratia marcescens demonstrate heightened lethality in space conditions compared to Earth. Antibiotic resistance is notably higher in space isolates, with 86.2% of ISS bacteria showing resistance versus 43.6% in ground controls, complicating treatment in resource-limited settings. These factors could lead to up to 90 infection events during a 950-day Mars mission, underscoring the need for vigilant environmental monitoring. A prominent example of 's impact on microbial behavior is the increased virulence of serovar Typhimurium, as demonstrated in experiments. Bacteria cultured during spaceflight or in microgravity simulators exhibit upregulated for invasion and survival factors, resulting in enhanced pathogenicity when tested in animal models; space-flown caused higher mortality rates in mice compared to Earth-grown strains. This hypervirulence stems from environmental cues like altered ion composition in growth media, which mimic gut conditions and trigger formation and acid tolerance. intestinal epithelial cell studies aboard the ISS further confirmed that spaceflight alters host responses to , with reduced inflammatory signaling and increased bacterial . These findings from NASA's Spaceflight-Induced Changes in Microbial Virulence experiments highlight the potential for common foodborne pathogens to become more dangerous during missions. To mitigate these risks, space agencies implement stringent , including sterile protocols and targeted prophylaxis. are equipped with nonsterile and sterile gloves, along with topical, oral, and intravenous for immediate use in treating , ocular, or systemic infections. Pre-mission and rigorous practices, such as surface disinfection and air , reduce initial , while onboard microbial monitoring via air, water, and surface sampling allows for early detection. Antibiotic prophylaxis is selectively used for high-risk procedures, though challenges like reduced drug potency—up to 50% degradation over 534 days—necessitate stable formulations. Emerging strategies include supplementation to bolster and to support immune function, as outlined in NASA's immunologic protocols for deep-space exploration. Beyond human-derived threats, considerations address the potential introduction of extraterrestrial microbes during sample return missions, particularly from Mars. NASA's policies classify Mars sample returns as Category V (restricted Earth return), requiring spacecraft sterilization to prevent forward and stringent for returned materials to avoid backward of Earth's . Concerns focus on viable Martian microbes surviving interplanetary travel and posing unknown risks to terrestrial , though assessments deem the probability low due to Mars' harsh conditions. Protocols include biohazard facilities for sample , with sterilization if bioactive agents are detected, as detailed in NASA's NPR 8715.24 and international COSPAR guidelines. These measures ensure that missions like Mars Sample Return prioritize both scientific discovery and global safety.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.